| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nitric Oxide | 98 | 2024 | 2135 | 7.130 |
Why?
|
| Glutathione Peroxidase | 36 | 2022 | 258 | 5.080 |
Why?
|
| Homocysteine | 35 | 2016 | 637 | 4.630 |
Why?
|
| Endothelium, Vascular | 82 | 2024 | 4433 | 4.270 |
Why?
|
| Oxidative Stress | 53 | 2024 | 3115 | 3.610 |
Why?
|
| Drug Repositioning | 9 | 2024 | 233 | 3.320 |
Why?
|
| Systems Biology | 16 | 2024 | 481 | 3.160 |
Why?
|
| Dyspnea | 14 | 2020 | 1347 | 3.100 |
Why?
|
| Oxidation-Reduction | 45 | 2024 | 2231 | 3.040 |
Why?
|
| Cardiovascular Diseases | 60 | 2023 | 15498 | 2.980 |
Why?
|
| Arteriosclerosis | 30 | 2007 | 1056 | 2.910 |
Why?
|
| Hyperhomocysteinemia | 22 | 2016 | 118 | 2.890 |
Why?
|
| Hypertension, Pulmonary | 30 | 2024 | 1582 | 2.510 |
Why?
|
| Selenium | 12 | 2022 | 417 | 2.420 |
Why?
|
| Thrombosis | 43 | 2020 | 2942 | 2.390 |
Why?
|
| Disease | 12 | 2021 | 670 | 2.320 |
Why?
|
| Diagnosis, Differential | 56 | 2020 | 12966 | 2.280 |
Why?
|
| Exanthema | 7 | 2020 | 503 | 2.230 |
Why?
|
| Blood Platelets | 56 | 2021 | 2478 | 2.120 |
Why?
|
| S-Nitrosothiols | 16 | 2012 | 35 | 2.020 |
Why?
|
| Reactive Oxygen Species | 32 | 2022 | 2137 | 1.960 |
Why?
|
| Selenoproteins | 9 | 2021 | 215 | 1.960 |
Why?
|
| Nitric Oxide Synthase | 36 | 2009 | 908 | 1.900 |
Why?
|
| Endothelial Cells | 23 | 2022 | 3550 | 1.880 |
Why?
|
| Computational Biology | 14 | 2024 | 3509 | 1.800 |
Why?
|
| Lung | 31 | 2024 | 9999 | 1.800 |
Why?
|
| Platelet Aggregation | 50 | 2018 | 771 | 1.790 |
Why?
|
| Humans | 558 | 2024 | 760740 | 1.680 |
Why?
|
| Nitroso Compounds | 22 | 2009 | 71 | 1.640 |
Why?
|
| Glucosephosphate Dehydrogenase | 13 | 2012 | 208 | 1.610 |
Why?
|
| Nitroglycerin | 15 | 2017 | 329 | 1.610 |
Why?
|
| Gene Regulatory Networks | 13 | 2021 | 1745 | 1.570 |
Why?
|
| NADP | 7 | 2019 | 227 | 1.550 |
Why?
|
| Cardiology | 9 | 2016 | 1656 | 1.550 |
Why?
|
| NAD | 8 | 2020 | 614 | 1.530 |
Why?
|
| Antioxidants | 27 | 2022 | 1669 | 1.520 |
Why?
|
| Drug Discovery | 9 | 2024 | 1051 | 1.520 |
Why?
|
| Periodicals as Topic | 10 | 2016 | 1463 | 1.500 |
Why?
|
| Glutathione | 26 | 2019 | 582 | 1.500 |
Why?
|
| Vasodilator Agents | 21 | 2015 | 973 | 1.460 |
Why?
|
| Biomedical Research | 15 | 2021 | 3426 | 1.450 |
Why?
|
| Chest Pain | 7 | 2022 | 1091 | 1.430 |
Why?
|
| Cyclic GMP | 31 | 2018 | 395 | 1.380 |
Why?
|
| Muscle, Smooth, Vascular | 23 | 2024 | 1492 | 1.370 |
Why?
|
| Nitric Oxide Synthase Type III | 22 | 2024 | 705 | 1.360 |
Why?
|
| Kidney | 19 | 2024 | 7044 | 1.330 |
Why?
|
| Arginine | 19 | 2021 | 933 | 1.310 |
Why?
|
| Cardiovascular System | 9 | 2016 | 834 | 1.290 |
Why?
|
| Abdominal Pain | 6 | 2020 | 1070 | 1.270 |
Why?
|
| Animals | 242 | 2024 | 168202 | 1.240 |
Why?
|
| Sulfhydryl Compounds | 17 | 2018 | 301 | 1.230 |
Why?
|
| Hemoptysis | 2 | 2021 | 151 | 1.220 |
Why?
|
| Myocardial Reperfusion Injury | 5 | 2022 | 481 | 1.200 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 7 | 2024 | 619 | 1.200 |
Why?
|
| Selenocysteine | 6 | 2022 | 127 | 1.190 |
Why?
|
| Vasodilation | 25 | 2018 | 962 | 1.170 |
Why?
|
| Mercaptoethanol | 12 | 1999 | 62 | 1.150 |
Why?
|
| Pheochromocytoma | 2 | 2021 | 328 | 1.150 |
Why?
|
| Cardiovascular Agents | 7 | 2021 | 840 | 1.150 |
Why?
|
| Myocardium | 16 | 2021 | 4725 | 1.130 |
Why?
|
| Coronary Vessels | 15 | 2021 | 3095 | 1.120 |
Why?
|
| Tissue Plasminogen Activator | 34 | 2002 | 1163 | 1.100 |
Why?
|
| Energy Metabolism | 5 | 2021 | 2878 | 1.090 |
Why?
|
| Myocarditis | 3 | 2023 | 788 | 1.080 |
Why?
|
| Foramen Ovale, Patent | 2 | 2019 | 208 | 1.070 |
Why?
|
| von Willebrand Factor | 12 | 2013 | 676 | 1.050 |
Why?
|
| von Willebrand Diseases | 3 | 2013 | 132 | 1.040 |
Why?
|
| Tricuspid Valve | 2 | 2019 | 409 | 1.040 |
Why?
|
| Fever | 10 | 2021 | 1618 | 1.020 |
Why?
|
| Adaptation, Physiological | 5 | 2016 | 1300 | 1.020 |
Why?
|
| Hydrogen Peroxide | 16 | 2022 | 730 | 1.020 |
Why?
|
| Immunocompromised Host | 4 | 2020 | 858 | 1.000 |
Why?
|
| Pulmonary Alveolar Proteinosis | 2 | 2019 | 41 | 0.990 |
Why?
|
| Fibrinolytic Agents | 18 | 2011 | 2073 | 0.980 |
Why?
|
| Folic Acid | 8 | 2013 | 1323 | 0.980 |
Why?
|
| Tricuspid Valve Insufficiency | 3 | 2019 | 352 | 0.970 |
Why?
|
| Foot Diseases | 3 | 2020 | 147 | 0.970 |
Why?
|
| Protein Interaction Mapping | 5 | 2023 | 615 | 0.970 |
Why?
|
| Proteome | 6 | 2021 | 1857 | 0.970 |
Why?
|
| Glucose | 8 | 2022 | 4345 | 0.960 |
Why?
|
| Dermatomyositis | 2 | 2019 | 258 | 0.960 |
Why?
|
| Fatal Outcome | 11 | 2021 | 1835 | 0.960 |
Why?
|
| Diarrhea | 4 | 2019 | 1317 | 0.950 |
Why?
|
| Platelet Activation | 19 | 2021 | 646 | 0.930 |
Why?
|
| Genomics | 10 | 2024 | 5822 | 0.920 |
Why?
|
| Intestinal Fistula | 2 | 2017 | 142 | 0.920 |
Why?
|
| Adrenal Gland Neoplasms | 2 | 2021 | 732 | 0.920 |
Why?
|
| Hypertension | 25 | 2021 | 8532 | 0.910 |
Why?
|
| Glycolysis | 5 | 2024 | 835 | 0.910 |
Why?
|
| Pharmacogenetics | 6 | 2019 | 675 | 0.910 |
Why?
|
| Cardiovascular Physiological Phenomena | 5 | 2021 | 241 | 0.910 |
Why?
|
| Phenotype | 20 | 2023 | 16572 | 0.900 |
Why?
|
| MicroRNAs | 11 | 2023 | 3802 | 0.900 |
Why?
|
| Cardiomyopathy, Hypertrophic | 4 | 2022 | 1310 | 0.900 |
Why?
|
| Cough | 10 | 2019 | 595 | 0.890 |
Why?
|
| Signal Transduction | 29 | 2024 | 23415 | 0.890 |
Why?
|
| Models, Biological | 16 | 2020 | 9461 | 0.880 |
Why?
|
| Gene Expression Regulation | 18 | 2021 | 11874 | 0.880 |
Why?
|
| Temporal Arteries | 2 | 2017 | 154 | 0.870 |
Why?
|
| Journal Impact Factor | 2 | 2015 | 153 | 0.870 |
Why?
|
| Hematemesis | 2 | 2021 | 22 | 0.860 |
Why?
|
| Platelet Aggregation Inhibitors | 28 | 2006 | 2746 | 0.860 |
Why?
|
| Myocardial Infarction | 28 | 2022 | 11458 | 0.850 |
Why?
|
| Polyarteritis Nodosa | 2 | 2014 | 70 | 0.850 |
Why?
|
| Duodenum | 2 | 2019 | 491 | 0.840 |
Why?
|
| Mitochondria | 11 | 2024 | 3619 | 0.830 |
Why?
|
| Angiodysplasia | 2 | 2013 | 22 | 0.830 |
Why?
|
| Academic Medical Centers | 5 | 2020 | 2756 | 0.830 |
Why?
|
| Shock, Cardiogenic | 3 | 2021 | 709 | 0.820 |
Why?
|
| Nitrogen Oxides | 6 | 2017 | 129 | 0.820 |
Why?
|
| Adrenal Glands | 2 | 2018 | 552 | 0.820 |
Why?
|
| Edema | 5 | 2018 | 765 | 0.810 |
Why?
|
| Oxidants | 8 | 2013 | 169 | 0.810 |
Why?
|
| Myocytes, Cardiac | 6 | 2021 | 1667 | 0.810 |
Why?
|
| Luminescent Proteins | 5 | 2020 | 836 | 0.810 |
Why?
|
| Nephritis, Interstitial | 2 | 2016 | 155 | 0.800 |
Why?
|
| Pulmonary Edema | 3 | 2021 | 407 | 0.800 |
Why?
|
| Fusobacterium necrophorum | 1 | 2021 | 14 | 0.780 |
Why?
|
| Coronary Disease | 19 | 2020 | 5911 | 0.780 |
Why?
|
| Tryptophan | 2 | 2021 | 482 | 0.780 |
Why?
|
| Lemierre Syndrome | 1 | 2021 | 14 | 0.770 |
Why?
|
| Cardiomyopathies | 7 | 2021 | 1948 | 0.770 |
Why?
|
| Hypophosphatemia | 2 | 2020 | 92 | 0.770 |
Why?
|
| Pulmonary Circulation | 8 | 2021 | 737 | 0.760 |
Why?
|
| Vascular Diseases | 10 | 2024 | 1159 | 0.750 |
Why?
|
| Endophenotypes | 3 | 2021 | 255 | 0.740 |
Why?
|
| Internal Medicine | 4 | 2017 | 1051 | 0.740 |
Why?
|
| Factor VIII | 2 | 2016 | 348 | 0.740 |
Why?
|
| Biopsy | 14 | 2020 | 6763 | 0.740 |
Why?
|
| Heart Neoplasms | 2 | 2019 | 362 | 0.730 |
Why?
|
| Metabolic Networks and Pathways | 6 | 2024 | 789 | 0.730 |
Why?
|
| Leptospirosis | 1 | 2021 | 31 | 0.730 |
Why?
|
| Heart Diseases | 6 | 2023 | 2778 | 0.720 |
Why?
|
| Placebo Effect | 3 | 2019 | 518 | 0.720 |
Why?
|
| Heparin | 18 | 2021 | 1632 | 0.720 |
Why?
|
| Nitric Oxide Donors | 9 | 2009 | 126 | 0.710 |
Why?
|
| Giant Cell Arteritis | 2 | 2017 | 306 | 0.710 |
Why?
|
| Metagenome | 2 | 2015 | 448 | 0.710 |
Why?
|
| Aldosterone | 10 | 2016 | 869 | 0.710 |
Why?
|
| Osteomalacia | 1 | 2020 | 60 | 0.700 |
Why?
|
| Mesenchymoma | 1 | 2020 | 49 | 0.700 |
Why?
|
| Metabolome | 4 | 2024 | 988 | 0.690 |
Why?
|
| Blood Pressure | 22 | 2019 | 8473 | 0.690 |
Why?
|
| Meningitis, Cryptococcal | 1 | 2020 | 67 | 0.690 |
Why?
|
| Genetic Predisposition to Disease | 20 | 2019 | 17878 | 0.690 |
Why?
|
| Nephrotic Syndrome | 2 | 2015 | 389 | 0.680 |
Why?
|
| Fibrinolysis | 15 | 2004 | 331 | 0.680 |
Why?
|
| Cryptococcus neoformans | 1 | 2020 | 120 | 0.680 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2019 | 1551 | 0.680 |
Why?
|
| Plasminogen | 8 | 2013 | 144 | 0.680 |
Why?
|
| Arachidonate 5-Lipoxygenase | 7 | 2021 | 128 | 0.680 |
Why?
|
| Coronary Thrombosis | 9 | 2002 | 440 | 0.680 |
Why?
|
| Gastrointestinal Hemorrhage | 4 | 2021 | 1116 | 0.670 |
Why?
|
| Lyme Neuroborreliosis | 1 | 2020 | 50 | 0.670 |
Why?
|
| Cells, Cultured | 54 | 2021 | 18937 | 0.670 |
Why?
|
| Pulmonary Artery | 15 | 2024 | 1927 | 0.650 |
Why?
|
| Celiac Disease | 2 | 2019 | 819 | 0.650 |
Why?
|
| Editorial Policies | 3 | 2016 | 458 | 0.650 |
Why?
|
| Drug Interactions | 5 | 2021 | 1415 | 0.640 |
Why?
|
| West Nile Fever | 1 | 2019 | 75 | 0.640 |
Why?
|
| Nitrates | 9 | 2009 | 263 | 0.640 |
Why?
|
| Proteomics | 6 | 2023 | 3836 | 0.640 |
Why?
|
| Typhus, Endemic Flea-Borne | 1 | 2018 | 4 | 0.640 |
Why?
|
| Blood Vessels | 7 | 2013 | 1112 | 0.630 |
Why?
|
| Male | 174 | 2024 | 360402 | 0.630 |
Why?
|
| Radiography | 16 | 2019 | 6961 | 0.620 |
Why?
|
| Meningoencephalitis | 1 | 2019 | 83 | 0.620 |
Why?
|
| Running | 1 | 2023 | 488 | 0.620 |
Why?
|
| Glutarates | 2 | 2022 | 243 | 0.620 |
Why?
|
| Glucocorticoids | 10 | 2017 | 2160 | 0.620 |
Why?
|
| Pharmaceutical Preparations | 2 | 2020 | 1086 | 0.620 |
Why?
|
| Empyema, Pleural | 1 | 2018 | 61 | 0.610 |
Why?
|
| Heart Failure | 19 | 2024 | 11670 | 0.610 |
Why?
|
| Nitric Oxide Synthase Type II | 15 | 2007 | 517 | 0.600 |
Why?
|
| Pulmonary Embolism | 15 | 2021 | 2568 | 0.600 |
Why?
|
| Hepatitis B | 2 | 2014 | 704 | 0.600 |
Why?
|
| Legionnaires' Disease | 1 | 2018 | 48 | 0.600 |
Why?
|
| Bone Diseases, Metabolic | 2 | 2014 | 409 | 0.600 |
Why?
|
| Legionella pneumophila | 1 | 2018 | 48 | 0.590 |
Why?
|
| Adenocarcinoma | 4 | 2020 | 6345 | 0.590 |
Why?
|
| Myocytes, Smooth Muscle | 10 | 2024 | 699 | 0.590 |
Why?
|
| Superior Vena Cava Syndrome | 1 | 2018 | 56 | 0.590 |
Why?
|
| Aryldialkylphosphatase | 3 | 2008 | 64 | 0.590 |
Why?
|
| Philosophy, Medical | 1 | 2017 | 79 | 0.580 |
Why?
|
| Copper | 3 | 2019 | 367 | 0.580 |
Why?
|
| Polymorphism, Genetic | 8 | 2012 | 4242 | 0.580 |
Why?
|
| Thrombolytic Therapy | 14 | 2002 | 2055 | 0.580 |
Why?
|
| Calcinosis | 3 | 2020 | 1469 | 0.580 |
Why?
|
| Eosinophilic Granuloma | 1 | 2017 | 27 | 0.580 |
Why?
|
| Opportunistic Infections | 1 | 2020 | 376 | 0.580 |
Why?
|
| Lipopolysaccharides | 5 | 2021 | 2202 | 0.580 |
Why?
|
| Kidney Diseases | 2 | 2023 | 2090 | 0.580 |
Why?
|
| Drugs, Investigational | 1 | 2019 | 212 | 0.580 |
Why?
|
| Coccidioides | 1 | 2017 | 18 | 0.580 |
Why?
|
| Stress, Physiological | 3 | 2015 | 1403 | 0.580 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 1 | 2018 | 49 | 0.580 |
Why?
|
| Recombinant Proteins | 26 | 2016 | 6520 | 0.580 |
Why?
|
| Biosensing Techniques | 4 | 2024 | 647 | 0.570 |
Why?
|
| Sarcomeres | 2 | 2022 | 369 | 0.570 |
Why?
|
| Clinical Trials as Topic | 18 | 2021 | 7995 | 0.570 |
Why?
|
| Venous Thrombosis | 6 | 2015 | 1303 | 0.570 |
Why?
|
| Osteomyelitis | 2 | 2021 | 407 | 0.570 |
Why?
|
| Virus Internalization | 1 | 2021 | 497 | 0.570 |
Why?
|
| Coccidioidomycosis | 1 | 2017 | 37 | 0.570 |
Why?
|
| Brugada Syndrome | 1 | 2018 | 91 | 0.560 |
Why?
|
| Social Medicine | 1 | 2017 | 64 | 0.560 |
Why?
|
| Headache | 4 | 2020 | 1255 | 0.560 |
Why?
|
| Medicine | 3 | 2022 | 942 | 0.560 |
Why?
|
| Apoptosis | 21 | 2016 | 9476 | 0.560 |
Why?
|
| Vibrio vulnificus | 1 | 2016 | 10 | 0.560 |
Why?
|
| Paraneoplastic Cerebellar Degeneration | 1 | 2016 | 13 | 0.560 |
Why?
|
| Inflammation | 14 | 2021 | 10759 | 0.550 |
Why?
|
| Antiphospholipid Syndrome | 1 | 2018 | 165 | 0.550 |
Why?
|
| Neovascularization, Physiologic | 9 | 2009 | 1349 | 0.550 |
Why?
|
| Vibrio Infections | 1 | 2016 | 33 | 0.550 |
Why?
|
| Glomerulonephritis | 1 | 2018 | 331 | 0.540 |
Why?
|
| Angioedema | 2 | 2016 | 184 | 0.540 |
Why?
|
| Echocardiography | 14 | 2020 | 4987 | 0.540 |
Why?
|
| Sodium Chloride, Dietary | 7 | 2011 | 292 | 0.540 |
Why?
|
| Shock | 2 | 2018 | 314 | 0.540 |
Why?
|
| Thromboembolism | 4 | 2019 | 991 | 0.540 |
Why?
|
| Cultural Diversity | 1 | 2020 | 369 | 0.530 |
Why?
|
| Cattle | 27 | 2012 | 3841 | 0.530 |
Why?
|
| Fever of Unknown Origin | 1 | 2016 | 94 | 0.530 |
Why?
|
| Vitamin B Complex | 4 | 2013 | 299 | 0.530 |
Why?
|
| Respiratory Sounds | 3 | 2019 | 702 | 0.530 |
Why?
|
| Gastric Bypass | 2 | 2017 | 818 | 0.530 |
Why?
|
| Gastric Fistula | 1 | 2017 | 73 | 0.530 |
Why?
|
| Takotsubo Cardiomyopathy | 1 | 2018 | 123 | 0.530 |
Why?
|
| Lipoproteins, LDL | 10 | 2008 | 642 | 0.520 |
Why?
|
| Leukocytes | 5 | 2021 | 2024 | 0.520 |
Why?
|
| Meningeal Carcinomatosis | 1 | 2016 | 63 | 0.520 |
Why?
|
| Contusions | 1 | 2016 | 79 | 0.520 |
Why?
|
| Pathology, Molecular | 1 | 2019 | 329 | 0.520 |
Why?
|
| Blastomyces | 1 | 2015 | 10 | 0.520 |
Why?
|
| Blastomycosis | 1 | 2015 | 14 | 0.510 |
Why?
|
| Fatty Acids | 4 | 2021 | 1808 | 0.510 |
Why?
|
| Kinetics | 21 | 2021 | 6370 | 0.510 |
Why?
|
| Dietary Supplements | 9 | 2016 | 3412 | 0.510 |
Why?
|
| Fibrinogen | 20 | 2014 | 887 | 0.510 |
Why?
|
| Rheumatic Heart Disease | 2 | 2014 | 163 | 0.510 |
Why?
|
| Hemostasis | 10 | 2012 | 469 | 0.510 |
Why?
|
| Female | 141 | 2024 | 392203 | 0.510 |
Why?
|
| Research Design | 8 | 2021 | 6174 | 0.510 |
Why?
|
| Malate Dehydrogenase | 1 | 2015 | 40 | 0.500 |
Why?
|
| Thrombotic Microangiopathies | 2 | 2020 | 123 | 0.500 |
Why?
|
| Antihypertensive Agents | 3 | 2019 | 2018 | 0.500 |
Why?
|
| Cysteine | 15 | 2012 | 891 | 0.500 |
Why?
|
| Genetic Heterogeneity | 1 | 2019 | 733 | 0.500 |
Why?
|
| Fibrinolysin | 11 | 1995 | 131 | 0.500 |
Why?
|
| Cryoglobulinemia | 1 | 2016 | 84 | 0.500 |
Why?
|
| Nephrosis, Lipoid | 1 | 2015 | 45 | 0.500 |
Why?
|
| Serum Albumin, Bovine | 5 | 1999 | 321 | 0.500 |
Why?
|
| Speech Disorders | 1 | 2016 | 180 | 0.500 |
Why?
|
| Intermittent Claudication | 1 | 2017 | 304 | 0.500 |
Why?
|
| Cephalosporins | 1 | 2016 | 198 | 0.500 |
Why?
|
| Abnormalities, Multiple | 2 | 2013 | 1422 | 0.500 |
Why?
|
| Cell Hypoxia | 9 | 2023 | 656 | 0.500 |
Why?
|
| Zinc | 1 | 2019 | 687 | 0.500 |
Why?
|
| Pathology, Clinical | 1 | 2019 | 376 | 0.490 |
Why?
|
| Algorithms | 8 | 2023 | 14024 | 0.490 |
Why?
|
| Colonic Diseases | 1 | 2017 | 201 | 0.490 |
Why?
|
| Mitral Valve Stenosis | 2 | 2014 | 341 | 0.490 |
Why?
|
| Leukemia, Hairy Cell | 1 | 2015 | 82 | 0.490 |
Why?
|
| Oxidoreductases | 2 | 2009 | 412 | 0.490 |
Why?
|
| Immune Reconstitution Inflammatory Syndrome | 1 | 2015 | 61 | 0.490 |
Why?
|
| Finger Injuries | 1 | 2016 | 145 | 0.490 |
Why?
|
| Electrocardiography | 11 | 2021 | 6346 | 0.490 |
Why?
|
| Immunoglobulin A | 2 | 2018 | 978 | 0.490 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2016 | 201 | 0.490 |
Why?
|
| Metabolomics | 6 | 2024 | 1656 | 0.490 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2016 | 214 | 0.490 |
Why?
|
| Mammals | 7 | 2022 | 1131 | 0.490 |
Why?
|
| Bleeding Time | 7 | 2011 | 83 | 0.480 |
Why?
|
| Lacerations | 1 | 2016 | 147 | 0.480 |
Why?
|
| Aspirin | 17 | 2018 | 3127 | 0.480 |
Why?
|
| Infarction | 2 | 2014 | 248 | 0.480 |
Why?
|
| Sweet Syndrome | 1 | 2015 | 58 | 0.480 |
Why?
|
| Diet | 7 | 2024 | 8049 | 0.480 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2019 | 423 | 0.480 |
Why?
|
| Thrombin | 11 | 1996 | 592 | 0.470 |
Why?
|
| Fatigue | 7 | 2019 | 1550 | 0.470 |
Why?
|
| Platelet Membrane Glycoproteins | 10 | 1996 | 284 | 0.460 |
Why?
|
| Wernicke Encephalopathy | 2 | 2012 | 29 | 0.460 |
Why?
|
| Molecular Biology | 4 | 2012 | 575 | 0.460 |
Why?
|
| Skin | 4 | 2016 | 4472 | 0.460 |
Why?
|
| Risk Factors | 48 | 2022 | 74128 | 0.460 |
Why?
|
| Citric Acid Cycle | 1 | 2015 | 231 | 0.460 |
Why?
|
| Oxygen | 5 | 2022 | 4226 | 0.460 |
Why?
|
| Terminology as Topic | 4 | 2017 | 1528 | 0.460 |
Why?
|
| Epigenesis, Genetic | 4 | 2021 | 3794 | 0.460 |
Why?
|
| Professional Autonomy | 2 | 2013 | 171 | 0.460 |
Why?
|
| Chitosan | 5 | 2021 | 131 | 0.460 |
Why?
|
| Minority Groups | 2 | 2020 | 1202 | 0.450 |
Why?
|
| Thrombophlebitis | 2 | 2014 | 289 | 0.450 |
Why?
|
| Prostatic Hyperplasia | 1 | 2018 | 521 | 0.450 |
Why?
|
| Fanconi Syndrome | 1 | 2014 | 34 | 0.450 |
Why?
|
| Angina, Unstable | 8 | 2008 | 888 | 0.450 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2016 | 373 | 0.450 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2021 | 4340 | 0.450 |
Why?
|
| Sjogren's Syndrome | 1 | 2016 | 237 | 0.450 |
Why?
|
| Philosophy | 1 | 2014 | 68 | 0.450 |
Why?
|
| Endothelium-Dependent Relaxing Factors | 1 | 2013 | 21 | 0.450 |
Why?
|
| Enterovirus Infections | 1 | 2014 | 74 | 0.440 |
Why?
|
| Middle Aged | 89 | 2024 | 220603 | 0.430 |
Why?
|
| Program Development | 4 | 2017 | 1293 | 0.430 |
Why?
|
| Tomography, X-Ray Computed | 17 | 2021 | 20556 | 0.430 |
Why?
|
| Transglutaminases | 1 | 2014 | 196 | 0.430 |
Why?
|
| Peroneal Nerve | 1 | 2013 | 76 | 0.430 |
Why?
|
| S-Adenosylhomocysteine | 3 | 2021 | 41 | 0.430 |
Why?
|
| Drug Eruptions | 1 | 2016 | 335 | 0.430 |
Why?
|
| Methylation | 9 | 2021 | 1077 | 0.430 |
Why?
|
| Fibrosis | 6 | 2021 | 2047 | 0.430 |
Why?
|
| Education, Medical, Graduate | 4 | 2019 | 2373 | 0.430 |
Why?
|
| Inflammation Mediators | 2 | 2021 | 1884 | 0.430 |
Why?
|
| Rheumatic Fever | 1 | 2013 | 73 | 0.430 |
Why?
|
| alpha-Galactosidase | 1 | 2013 | 57 | 0.430 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 11 | 1996 | 426 | 0.430 |
Why?
|
| Tachycardia, Ventricular | 2 | 2013 | 1261 | 0.420 |
Why?
|
| Interferon-gamma | 1 | 2021 | 3145 | 0.420 |
Why?
|
| Endemic Diseases | 1 | 2014 | 191 | 0.420 |
Why?
|
| Lung Diseases | 6 | 2021 | 1909 | 0.420 |
Why?
|
| Chagas Cardiomyopathy | 1 | 2013 | 71 | 0.420 |
Why?
|
| Blood | 2 | 2014 | 596 | 0.420 |
Why?
|
| Protein Processing, Post-Translational | 4 | 2016 | 1971 | 0.420 |
Why?
|
| Disease Susceptibility | 2 | 2018 | 1788 | 0.420 |
Why?
|
| Hemophilia A | 1 | 2016 | 359 | 0.420 |
Why?
|
| Dose-Response Relationship, Drug | 29 | 2016 | 10754 | 0.420 |
Why?
|
| Hantavirus Pulmonary Syndrome | 1 | 2012 | 11 | 0.420 |
Why?
|
| Vascular Fistula | 1 | 2013 | 50 | 0.420 |
Why?
|
| Atherosclerosis | 8 | 2018 | 3400 | 0.420 |
Why?
|
| Disulfides | 5 | 2009 | 464 | 0.420 |
Why?
|
| Aortic Valve Stenosis | 3 | 2018 | 2003 | 0.410 |
Why?
|
| Hypothyroidism | 2 | 2015 | 668 | 0.410 |
Why?
|
| Computer Simulation | 4 | 2019 | 6233 | 0.410 |
Why?
|
| Plasmodium vivax | 1 | 2014 | 202 | 0.410 |
Why?
|
| Clinical Medicine | 1 | 2014 | 145 | 0.410 |
Why?
|
| Malaria, Vivax | 1 | 2014 | 166 | 0.410 |
Why?
|
| Leiomyosarcoma | 1 | 2016 | 422 | 0.410 |
Why?
|
| Duodenal Diseases | 1 | 2013 | 99 | 0.410 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 4 | 2001 | 283 | 0.410 |
Why?
|
| Thrombophilia | 4 | 2014 | 306 | 0.410 |
Why?
|
| Fabry Disease | 1 | 2013 | 87 | 0.410 |
Why?
|
| Rats | 37 | 2024 | 23716 | 0.410 |
Why?
|
| Tuberculosis | 3 | 2017 | 2015 | 0.400 |
Why?
|
| Aorta | 11 | 2011 | 2041 | 0.400 |
Why?
|
| Acetylcysteine | 9 | 1996 | 260 | 0.400 |
Why?
|
| Cachexia | 1 | 2014 | 202 | 0.400 |
Why?
|
| National Institutes of Health (U.S.) | 6 | 2020 | 793 | 0.400 |
Why?
|
| Methylamines | 1 | 2013 | 136 | 0.400 |
Why?
|
| Mice | 59 | 2024 | 81368 | 0.400 |
Why?
|
| Protein Engineering | 3 | 2017 | 548 | 0.400 |
Why?
|
| Adenosine Diphosphate | 13 | 2020 | 422 | 0.400 |
Why?
|
| Pre-Eclampsia | 5 | 2023 | 1230 | 0.400 |
Why?
|
| Adult | 79 | 2024 | 220995 | 0.390 |
Why?
|
| Doxorubicin | 1 | 2018 | 2224 | 0.390 |
Why?
|
| Mycobacterium tuberculosis | 2 | 2015 | 1914 | 0.390 |
Why?
|
| Coronary Artery Disease | 12 | 2018 | 6403 | 0.390 |
Why?
|
| Thiamine Deficiency | 1 | 2012 | 48 | 0.390 |
Why?
|
| Radiotherapy | 1 | 2019 | 1497 | 0.390 |
Why?
|
| Thyroxine | 1 | 2015 | 666 | 0.390 |
Why?
|
| Lipid Peroxides | 3 | 2008 | 74 | 0.390 |
Why?
|
| Histoplasma | 1 | 2011 | 39 | 0.390 |
Why?
|
| Intestinal Polyposis | 1 | 2012 | 42 | 0.390 |
Why?
|
| Gene Expression Profiling | 9 | 2024 | 9417 | 0.390 |
Why?
|
| Myocardial Contraction | 10 | 2011 | 1515 | 0.390 |
Why?
|
| Tracheomalacia | 1 | 2012 | 63 | 0.390 |
Why?
|
| Phosphates | 4 | 2022 | 769 | 0.390 |
Why?
|
| Homeostasis | 9 | 2019 | 3321 | 0.390 |
Why?
|
| Nose | 1 | 2015 | 521 | 0.390 |
Why?
|
| Free Radical Scavengers | 2 | 2021 | 211 | 0.380 |
Why?
|
| Rabbits | 27 | 2003 | 4770 | 0.380 |
Why?
|
| Glomerulonephritis, Membranous | 1 | 2012 | 87 | 0.380 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 2015 | 335 | 0.380 |
Why?
|
| Cardiomegaly | 3 | 2013 | 590 | 0.380 |
Why?
|
| Histoplasmosis | 1 | 2011 | 63 | 0.380 |
Why?
|
| Phosphatidylcholines | 1 | 2013 | 405 | 0.380 |
Why?
|
| Hirudin Therapy | 7 | 1996 | 43 | 0.380 |
Why?
|
| Hirudins | 7 | 1996 | 179 | 0.380 |
Why?
|
| Pruritus | 1 | 2015 | 378 | 0.380 |
Why?
|
| Dextran Sulfate | 7 | 2021 | 258 | 0.380 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 1 | 2012 | 93 | 0.380 |
Why?
|
| Asthma | 8 | 2023 | 6234 | 0.380 |
Why?
|
| Trypanosoma cruzi | 1 | 2013 | 206 | 0.380 |
Why?
|
| Vasomotor System | 2 | 2002 | 207 | 0.380 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2012 | 296 | 0.370 |
Why?
|
| Lung Neoplasms | 5 | 2020 | 13383 | 0.370 |
Why?
|
| Certification | 1 | 2014 | 418 | 0.370 |
Why?
|
| Stomach | 2 | 2014 | 696 | 0.370 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 6 | 2009 | 94 | 0.370 |
Why?
|
| Bone Marrow | 2 | 2019 | 2909 | 0.370 |
Why?
|
| Gene Expression Regulation, Enzymologic | 4 | 2017 | 1169 | 0.370 |
Why?
|
| Mutation | 19 | 2022 | 30015 | 0.370 |
Why?
|
| Travel | 4 | 2021 | 796 | 0.370 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2013 | 240 | 0.360 |
Why?
|
| Streptococcus pyogenes | 1 | 2013 | 292 | 0.360 |
Why?
|
| Peptic Ulcer Hemorrhage | 1 | 2010 | 48 | 0.360 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2012 | 177 | 0.360 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2014 | 621 | 0.360 |
Why?
|
| Manuscripts as Topic | 1 | 2010 | 15 | 0.360 |
Why?
|
| Therapeutics | 1 | 2011 | 113 | 0.360 |
Why?
|
| Community Networks | 1 | 2012 | 201 | 0.360 |
Why?
|
| Kidney Glomerulus | 1 | 2013 | 568 | 0.360 |
Why?
|
| Fibrin | 10 | 1996 | 507 | 0.360 |
Why?
|
| Syncope | 1 | 2013 | 428 | 0.350 |
Why?
|
| Insulinoma | 1 | 2011 | 121 | 0.350 |
Why?
|
| Microscopy, Fluorescence | 5 | 2019 | 2639 | 0.350 |
Why?
|
| Protein Biosynthesis | 4 | 2019 | 2100 | 0.350 |
Why?
|
| Stem Cells | 5 | 2012 | 3514 | 0.350 |
Why?
|
| Prions | 1 | 2012 | 180 | 0.350 |
Why?
|
| Omeprazole | 1 | 2010 | 105 | 0.350 |
Why?
|
| GTP-Binding Proteins | 1 | 2014 | 949 | 0.350 |
Why?
|
| Streptokinase | 6 | 1995 | 186 | 0.340 |
Why?
|
| Adenine | 2 | 2014 | 985 | 0.340 |
Why?
|
| Intention | 1 | 2013 | 346 | 0.340 |
Why?
|
| Anti-Ulcer Agents | 1 | 2010 | 112 | 0.340 |
Why?
|
| Arthroplasty, Replacement, Knee | 2 | 2021 | 1393 | 0.340 |
Why?
|
| Nanoparticles | 6 | 2021 | 1957 | 0.340 |
Why?
|
| Hemoglobins | 5 | 2019 | 1524 | 0.340 |
Why?
|
| Adult Stem Cells | 1 | 2012 | 221 | 0.340 |
Why?
|
| Molecular Targeted Therapy | 4 | 2019 | 2812 | 0.340 |
Why?
|
| Interdisciplinary Communication | 2 | 2016 | 928 | 0.340 |
Why?
|
| Forecasting | 7 | 2021 | 2924 | 0.340 |
Why?
|
| Urokinase-Type Plasminogen Activator | 9 | 1996 | 325 | 0.340 |
Why?
|
| Radiography, Thoracic | 3 | 2021 | 1302 | 0.340 |
Why?
|
| RNA, Messenger | 19 | 2023 | 12759 | 0.340 |
Why?
|
| Government Regulation | 2 | 2017 | 524 | 0.340 |
Why?
|
| Arteries | 5 | 2004 | 1120 | 0.330 |
Why?
|
| Free Radicals | 2 | 2009 | 238 | 0.330 |
Why?
|
| Genetic Techniques | 1 | 2012 | 428 | 0.330 |
Why?
|
| Goals | 2 | 2014 | 708 | 0.330 |
Why?
|
| Autoimmune Diseases | 2 | 2023 | 2238 | 0.330 |
Why?
|
| Iron-Sulfur Proteins | 1 | 2009 | 83 | 0.330 |
Why?
|
| Science | 1 | 2012 | 239 | 0.330 |
Why?
|
| Monocytes | 6 | 2010 | 2565 | 0.320 |
Why?
|
| Arthralgia | 1 | 2013 | 461 | 0.320 |
Why?
|
| Genital Diseases, Female | 1 | 2010 | 192 | 0.320 |
Why?
|
| Epoprostenol | 7 | 2005 | 247 | 0.320 |
Why?
|
| Liver Function Tests | 4 | 2016 | 524 | 0.320 |
Why?
|
| Intracranial Thrombosis | 2 | 2007 | 108 | 0.320 |
Why?
|
| Radiography, Abdominal | 4 | 2014 | 534 | 0.320 |
Why?
|
| Lipoprotein(a) | 8 | 1996 | 479 | 0.320 |
Why?
|
| Diuretics | 2 | 2013 | 611 | 0.320 |
Why?
|
| Vascular Resistance | 6 | 2024 | 930 | 0.320 |
Why?
|
| Publishing | 2 | 2016 | 832 | 0.320 |
Why?
|
| Mastocytosis, Systemic | 1 | 2010 | 103 | 0.310 |
Why?
|
| Peer Review | 1 | 2011 | 217 | 0.310 |
Why?
|
| Antithrombin III | 4 | 1996 | 128 | 0.310 |
Why?
|
| Confusion | 1 | 2011 | 278 | 0.310 |
Why?
|
| Nitrosation | 7 | 2012 | 25 | 0.310 |
Why?
|
| Osteogenesis Imperfecta | 1 | 2009 | 81 | 0.310 |
Why?
|
| Gastrointestinal Tract | 2 | 2012 | 834 | 0.310 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2011 | 682 | 0.310 |
Why?
|
| Defibrillators, Implantable | 1 | 2018 | 1483 | 0.310 |
Why?
|
| Low Back Pain | 1 | 2017 | 982 | 0.310 |
Why?
|
| Rare Diseases | 3 | 2019 | 622 | 0.310 |
Why?
|
| Nitro Compounds | 2 | 2003 | 74 | 0.310 |
Why?
|
| Prednisone | 5 | 2017 | 1562 | 0.310 |
Why?
|
| Regenerative Medicine | 1 | 2012 | 306 | 0.310 |
Why?
|
| Intestine, Small | 1 | 2014 | 1207 | 0.310 |
Why?
|
| Cholesterol | 11 | 2016 | 2902 | 0.310 |
Why?
|
| Mitochondria, Liver | 1 | 2009 | 190 | 0.300 |
Why?
|
| Liver | 12 | 2020 | 7512 | 0.300 |
Why?
|
| Promoter Regions, Genetic | 6 | 2011 | 5780 | 0.300 |
Why?
|
| Eosinophilia | 2 | 2010 | 559 | 0.300 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2016 | 940 | 0.300 |
Why?
|
| Postoperative Complications | 5 | 2021 | 15609 | 0.300 |
Why?
|
| Databases, Genetic | 2 | 2012 | 1742 | 0.300 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 6 | 1996 | 144 | 0.300 |
Why?
|
| Adenosine Triphosphate | 4 | 2020 | 1988 | 0.300 |
Why?
|
| Fractures, Bone | 1 | 2020 | 2045 | 0.300 |
Why?
|
| History, 20th Century | 5 | 2017 | 2764 | 0.300 |
Why?
|
| Brain | 11 | 2020 | 27100 | 0.300 |
Why?
|
| Hypopituitarism | 1 | 2010 | 250 | 0.300 |
Why?
|
| Acute Coronary Syndrome | 5 | 2012 | 2190 | 0.290 |
Why?
|
| Anti-Bacterial Agents | 5 | 2021 | 7403 | 0.290 |
Why?
|
| Uveitis | 1 | 2011 | 396 | 0.290 |
Why?
|
| Prothrombin | 2 | 1999 | 190 | 0.290 |
Why?
|
| Lipoproteins | 8 | 2012 | 879 | 0.290 |
Why?
|
| Endometrium | 1 | 2010 | 403 | 0.290 |
Why?
|
| Superoxides | 8 | 2006 | 387 | 0.290 |
Why?
|
| Guanylate Cyclase | 8 | 2013 | 205 | 0.290 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2011 | 485 | 0.290 |
Why?
|
| Gastroenteritis | 1 | 2009 | 236 | 0.290 |
Why?
|
| Uterine Neoplasms | 1 | 2016 | 1420 | 0.290 |
Why?
|
| Interdisciplinary Studies | 2 | 2018 | 86 | 0.290 |
Why?
|
| Societies, Medical | 3 | 2011 | 3901 | 0.290 |
Why?
|
| Peptide Fragments | 8 | 2000 | 5109 | 0.290 |
Why?
|
| Sarcoma | 1 | 2019 | 1800 | 0.290 |
Why?
|
| Sarcoidosis | 2 | 2010 | 520 | 0.290 |
Why?
|
| Pain | 3 | 2017 | 5062 | 0.290 |
Why?
|
| Homocystine | 5 | 2004 | 21 | 0.290 |
Why?
|
| Anticoagulants | 5 | 2011 | 4785 | 0.290 |
Why?
|
| Methyltransferases | 3 | 2015 | 373 | 0.290 |
Why?
|
| Randomized Controlled Trials as Topic | 7 | 2019 | 10203 | 0.280 |
Why?
|
| Entrepreneurship | 1 | 2007 | 23 | 0.280 |
Why?
|
| Bibliometrics | 1 | 2011 | 352 | 0.280 |
Why?
|
| Databases, Factual | 3 | 2024 | 7963 | 0.280 |
Why?
|
| Lipid Metabolism | 2 | 2016 | 1896 | 0.280 |
Why?
|
| Heart Ventricles | 3 | 2019 | 3796 | 0.280 |
Why?
|
| Receptors, LDL | 5 | 2021 | 488 | 0.280 |
Why?
|
| Physician's Role | 2 | 2013 | 917 | 0.280 |
Why?
|
| Magnetic Resonance Imaging | 14 | 2021 | 36401 | 0.280 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 8 | 2003 | 1517 | 0.280 |
Why?
|
| Immunoglobulin G | 4 | 2016 | 4533 | 0.270 |
Why?
|
| Aged | 53 | 2024 | 169092 | 0.270 |
Why?
|
| Patient Care Management | 1 | 2010 | 302 | 0.270 |
Why?
|
| Enzyme Activation | 10 | 2011 | 3591 | 0.270 |
Why?
|
| Blood Proteins | 4 | 2016 | 1172 | 0.270 |
Why?
|
| Leg | 3 | 2017 | 1087 | 0.270 |
Why?
|
| Megakaryocytes | 2 | 2001 | 566 | 0.270 |
Why?
|
| Cell Proliferation | 13 | 2021 | 10429 | 0.270 |
Why?
|
| Catheters, Indwelling | 2 | 2019 | 426 | 0.270 |
Why?
|
| Stroke | 9 | 2014 | 9715 | 0.270 |
Why?
|
| Mice, Knockout | 20 | 2024 | 14388 | 0.270 |
Why?
|
| Extracellular Fluid | 1 | 2008 | 165 | 0.270 |
Why?
|
| Fluorescence | 3 | 2020 | 756 | 0.270 |
Why?
|
| Arterial Occlusive Diseases | 2 | 2003 | 748 | 0.270 |
Why?
|
| Reproducibility of Results | 8 | 2022 | 20077 | 0.270 |
Why?
|
| Factor XIII | 5 | 2007 | 59 | 0.260 |
Why?
|
| Health Policy | 3 | 2020 | 2682 | 0.260 |
Why?
|
| Lymphatic Diseases | 3 | 2015 | 320 | 0.260 |
Why?
|
| Job Satisfaction | 1 | 2010 | 544 | 0.260 |
Why?
|
| Genotype | 9 | 2020 | 12977 | 0.260 |
Why?
|
| Cells | 1 | 2007 | 164 | 0.260 |
Why?
|
| Hemorrhage | 5 | 2011 | 3418 | 0.260 |
Why?
|
| Genetic Association Studies | 3 | 2021 | 2734 | 0.260 |
Why?
|
| Cell Membrane | 8 | 2008 | 3680 | 0.260 |
Why?
|
| Disease Models, Animal | 21 | 2024 | 18220 | 0.260 |
Why?
|
| Collagen Type I | 1 | 2009 | 616 | 0.260 |
Why?
|
| Lactic Acid | 3 | 2024 | 1139 | 0.260 |
Why?
|
| Tunica Intima | 2 | 2000 | 458 | 0.250 |
Why?
|
| Intestinal Obstruction | 1 | 2009 | 432 | 0.250 |
Why?
|
| Cell Survival | 10 | 2017 | 5780 | 0.250 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2007 | 321 | 0.250 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2020 | 5671 | 0.250 |
Why?
|
| Pyruvic Acid | 2 | 2019 | 203 | 0.250 |
Why?
|
| Heart | 10 | 2024 | 4403 | 0.250 |
Why?
|
| Oxygenases | 1 | 2005 | 59 | 0.250 |
Why?
|
| Protein Binding | 11 | 2021 | 9345 | 0.250 |
Why?
|
| Aminoglycosides | 1 | 2005 | 160 | 0.240 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2023 | 988 | 0.240 |
Why?
|
| Captopril | 3 | 1991 | 265 | 0.240 |
Why?
|
| Liver Neoplasms | 3 | 2010 | 4309 | 0.240 |
Why?
|
| Neoplasms | 8 | 2021 | 22131 | 0.240 |
Why?
|
| Ischemia | 5 | 2014 | 1885 | 0.240 |
Why?
|
| Psychiatry | 1 | 2017 | 1693 | 0.240 |
Why?
|
| Catechol O-Methyltransferase | 2 | 2019 | 251 | 0.240 |
Why?
|
| Research Support as Topic | 3 | 2006 | 697 | 0.240 |
Why?
|
| Mesentery | 2 | 2002 | 202 | 0.240 |
Why?
|
| Vitamin B 6 | 1 | 2006 | 234 | 0.240 |
Why?
|
| Cell Adhesion Molecules | 4 | 2010 | 1602 | 0.240 |
Why?
|
| Apolipoproteins E | 3 | 2006 | 1443 | 0.240 |
Why?
|
| Patient Education as Topic | 1 | 2014 | 2315 | 0.230 |
Why?
|
| Genome, Human | 5 | 2021 | 4421 | 0.230 |
Why?
|
| Catalase | 4 | 2009 | 218 | 0.230 |
Why?
|
| Infertility, Female | 1 | 2010 | 760 | 0.230 |
Why?
|
| Budgets | 1 | 2006 | 230 | 0.230 |
Why?
|
| Ethics, Professional | 1 | 2004 | 100 | 0.230 |
Why?
|
| Delayed Diagnosis | 2 | 2021 | 463 | 0.230 |
Why?
|
| Clinical Competence | 3 | 2014 | 4790 | 0.230 |
Why?
|
| Social Responsibility | 2 | 2020 | 385 | 0.230 |
Why?
|
| Cyclooxygenase Inhibitors | 2 | 2005 | 361 | 0.230 |
Why?
|
| Chemokine CXCL12 | 3 | 2016 | 454 | 0.230 |
Why?
|
| Workload | 1 | 2010 | 844 | 0.230 |
Why?
|
| Bronchoscopy | 2 | 2021 | 909 | 0.230 |
Why?
|
| Pancreas | 1 | 2011 | 1691 | 0.230 |
Why?
|
| Blood Cell Count | 2 | 2018 | 397 | 0.230 |
Why?
|
| Physician-Patient Relations | 2 | 2014 | 3239 | 0.230 |
Why?
|
| Intestines | 1 | 2013 | 1909 | 0.230 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2021 | 2896 | 0.230 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2004 | 167 | 0.230 |
Why?
|
| Membrane Fluidity | 5 | 1990 | 68 | 0.220 |
Why?
|
| Nitroprusside | 11 | 2003 | 272 | 0.220 |
Why?
|
| Stomach Neoplasms | 1 | 2014 | 1459 | 0.220 |
Why?
|
| Risk Assessment | 8 | 2021 | 23974 | 0.220 |
Why?
|
| Amyloidosis | 1 | 2010 | 815 | 0.220 |
Why?
|
| Ascomycota | 1 | 2024 | 81 | 0.220 |
Why?
|
| NF-kappa B | 4 | 2015 | 2481 | 0.220 |
Why?
|
| Hypoglycemia | 1 | 2011 | 883 | 0.220 |
Why?
|
| S-Adenosylmethionine | 3 | 2021 | 218 | 0.220 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 2024 | 132 | 0.220 |
Why?
|
| Glycine | 3 | 2009 | 661 | 0.220 |
Why?
|
| Tachyphylaxis | 1 | 2003 | 54 | 0.220 |
Why?
|
| Drug Industry | 2 | 2007 | 788 | 0.220 |
Why?
|
| Pilot Projects | 9 | 2019 | 8619 | 0.220 |
Why?
|
| Coronary Angiography | 9 | 2022 | 4470 | 0.220 |
Why?
|
| Nausea | 2 | 2019 | 679 | 0.220 |
Why?
|
| Cell Line | 14 | 2018 | 15577 | 0.210 |
Why?
|
| alpha-Crystallin B Chain | 2 | 2016 | 24 | 0.210 |
Why?
|
| Endothelial Growth Factors | 3 | 2003 | 673 | 0.210 |
Why?
|
| Deglutition Disorders | 2 | 2021 | 627 | 0.210 |
Why?
|
| Dementia | 2 | 2012 | 2686 | 0.210 |
Why?
|
| Membrane Proteins | 7 | 2015 | 7847 | 0.210 |
Why?
|
| Genetic Variation | 7 | 2018 | 6561 | 0.210 |
Why?
|
| Anorexia | 2 | 2016 | 154 | 0.210 |
Why?
|
| Internship and Residency | 3 | 2017 | 5878 | 0.210 |
Why?
|
| Vitamin B 12 | 1 | 2006 | 524 | 0.210 |
Why?
|
| Membrane Lipids | 5 | 1990 | 252 | 0.210 |
Why?
|
| Cystathionine beta-Synthase | 4 | 2005 | 27 | 0.210 |
Why?
|
| Adenosine | 2 | 2005 | 805 | 0.210 |
Why?
|
| Education, Medical | 1 | 2014 | 1725 | 0.210 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 2 | 2021 | 323 | 0.210 |
Why?
|
| Apyrase | 2 | 2005 | 373 | 0.210 |
Why?
|
| P-Selectin | 8 | 2011 | 599 | 0.210 |
Why?
|
| Mice, Inbred C57BL | 16 | 2021 | 22117 | 0.210 |
Why?
|
| Plasminogen Activators | 4 | 1990 | 199 | 0.210 |
Why?
|
| Bradykinin | 5 | 2002 | 208 | 0.210 |
Why?
|
| Cell Adhesion | 6 | 2021 | 3088 | 0.210 |
Why?
|
| Lymphokines | 3 | 2003 | 925 | 0.210 |
Why?
|
| Transcription Factors | 6 | 2019 | 12116 | 0.210 |
Why?
|
| Pancreatic Neoplasms | 2 | 2011 | 5369 | 0.200 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2018 | 604 | 0.200 |
Why?
|
| Bone Morphogenetic Protein 2 | 3 | 2016 | 343 | 0.200 |
Why?
|
| Liver Diseases | 1 | 2011 | 1297 | 0.200 |
Why?
|
| Chromatography, High Pressure Liquid | 6 | 2019 | 1540 | 0.200 |
Why?
|
| Financing, Government | 1 | 2006 | 472 | 0.200 |
Why?
|
| Stress, Mechanical | 4 | 2022 | 1674 | 0.200 |
Why?
|
| Platelet Adhesiveness | 6 | 1997 | 154 | 0.200 |
Why?
|
| Esterases | 1 | 2002 | 98 | 0.200 |
Why?
|
| Hyperlipidemias | 4 | 2016 | 770 | 0.200 |
Why?
|
| Hypercholesterolemia | 6 | 2012 | 1141 | 0.200 |
Why?
|
| Leukocyte Count | 3 | 2018 | 1597 | 0.200 |
Why?
|
| Regeneration | 4 | 2012 | 1505 | 0.200 |
Why?
|
| Thyrotropin | 2 | 2016 | 834 | 0.200 |
Why?
|
| Hematinics | 2 | 2003 | 282 | 0.200 |
Why?
|
| Myocardial Stunning | 1 | 2002 | 66 | 0.200 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2024 | 269 | 0.200 |
Why?
|
| Amino Acid Oxidoreductases | 6 | 1995 | 149 | 0.200 |
Why?
|
| Transcriptional Activation | 3 | 2010 | 1754 | 0.200 |
Why?
|
| Creatinine | 3 | 2018 | 1895 | 0.200 |
Why?
|
| Pterins | 1 | 2001 | 11 | 0.200 |
Why?
|
| Communication | 2 | 2014 | 3851 | 0.200 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2019 | 888 | 0.200 |
Why?
|
| Polymorphism, Single Nucleotide | 10 | 2019 | 15908 | 0.200 |
Why?
|
| COS Cells | 4 | 2009 | 1130 | 0.200 |
Why?
|
| Fluorobenzenes | 3 | 2012 | 179 | 0.190 |
Why?
|
| Antibodies, Monoclonal | 6 | 2016 | 9171 | 0.190 |
Why?
|
| Biology | 1 | 2024 | 290 | 0.190 |
Why?
|
| Diabetes Mellitus, Type 1 | 3 | 2018 | 3415 | 0.190 |
Why?
|
| Prognosis | 9 | 2021 | 29601 | 0.190 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 2 | 2012 | 158 | 0.190 |
Why?
|
| Extracellular Space | 2 | 2017 | 562 | 0.190 |
Why?
|
| Lipid Peroxidation | 5 | 2009 | 271 | 0.190 |
Why?
|
| S-Nitrosoglutathione | 5 | 2001 | 23 | 0.190 |
Why?
|
| Nephrosclerosis | 1 | 2001 | 11 | 0.190 |
Why?
|
| Alprostadil | 3 | 1990 | 86 | 0.190 |
Why?
|
| Blood Coagulation Factors | 4 | 2016 | 366 | 0.190 |
Why?
|
| Weight Loss | 4 | 2017 | 2682 | 0.190 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2012 | 1642 | 0.190 |
Why?
|
| Pituitary Neoplasms | 1 | 2010 | 1323 | 0.190 |
Why?
|
| Pulmonary Wedge Pressure | 6 | 2012 | 273 | 0.190 |
Why?
|
| Knowledge | 1 | 2023 | 177 | 0.190 |
Why?
|
| Systems Analysis | 2 | 2017 | 169 | 0.190 |
Why?
|
| Deamino Arginine Vasopressin | 2 | 1991 | 87 | 0.190 |
Why?
|
| Leukocyte Rolling | 1 | 2021 | 69 | 0.190 |
Why?
|
| Virus Attachment | 1 | 2021 | 55 | 0.190 |
Why?
|
| Community-Acquired Infections | 2 | 2018 | 469 | 0.190 |
Why?
|
| Immunity | 3 | 2018 | 994 | 0.190 |
Why?
|
| Brain Ischemia | 2 | 2006 | 3030 | 0.180 |
Why?
|
| Vasoconstriction | 5 | 1999 | 592 | 0.180 |
Why?
|
| Models, Animal | 7 | 2021 | 2108 | 0.180 |
Why?
|
| Bundle-Branch Block | 2 | 2013 | 276 | 0.180 |
Why?
|
| Kynurenine | 1 | 2021 | 141 | 0.180 |
Why?
|
| Muscle, Skeletal | 1 | 2016 | 4947 | 0.180 |
Why?
|
| Hepatomegaly | 2 | 2011 | 84 | 0.180 |
Why?
|
| Demography | 3 | 2018 | 1643 | 0.180 |
Why?
|
| Physicians | 3 | 2022 | 4583 | 0.180 |
Why?
|
| Immunotherapy | 1 | 2016 | 4642 | 0.180 |
Why?
|
| Drug Therapy, Combination | 6 | 2013 | 6305 | 0.180 |
Why?
|
| Partial Thromboplastin Time | 4 | 2016 | 204 | 0.180 |
Why?
|
| Spironolactone | 4 | 2016 | 409 | 0.180 |
Why?
|
| Neuropilin-1 | 1 | 2021 | 90 | 0.180 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type II | 3 | 2008 | 72 | 0.180 |
Why?
|
| Thorax | 2 | 2023 | 555 | 0.180 |
Why?
|
| Thrombocytosis | 1 | 2001 | 88 | 0.180 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2020 | 3798 | 0.180 |
Why?
|
| Gene Expression | 4 | 2021 | 7569 | 0.180 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2010 | 2270 | 0.180 |
Why?
|
| Fingers | 2 | 2016 | 506 | 0.180 |
Why?
|
| Open Reading Frames | 1 | 2004 | 813 | 0.180 |
Why?
|
| Cell Transdifferentiation | 1 | 2021 | 186 | 0.180 |
Why?
|
| Ozone | 1 | 2004 | 483 | 0.180 |
Why?
|
| Pregnancy Complications | 1 | 2014 | 2948 | 0.180 |
Why?
|
| Plasmapheresis | 1 | 2021 | 206 | 0.180 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-3 | 1 | 2000 | 34 | 0.170 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2002 | 284 | 0.170 |
Why?
|
| Drug Combinations | 5 | 2023 | 2048 | 0.170 |
Why?
|
| Lymph Nodes | 3 | 2020 | 3461 | 0.170 |
Why?
|
| United States | 21 | 2021 | 72292 | 0.170 |
Why?
|
| Coculture Techniques | 2 | 2021 | 1336 | 0.170 |
Why?
|
| History, 18th Century | 2 | 2017 | 206 | 0.170 |
Why?
|
| Amiodarone | 2 | 2013 | 217 | 0.170 |
Why?
|
| Hematologic Tests | 2 | 2012 | 239 | 0.170 |
Why?
|
| Authorship | 3 | 2014 | 284 | 0.170 |
Why?
|
| Periodicity | 2 | 2000 | 347 | 0.170 |
Why?
|
| Nedocromil | 1 | 2019 | 45 | 0.170 |
Why?
|
| Borrelia | 1 | 2020 | 66 | 0.170 |
Why?
|
| Methionine | 4 | 2013 | 572 | 0.170 |
Why?
|
| Anemia, Hypochromic | 1 | 2019 | 63 | 0.170 |
Why?
|
| Pharyngitis | 1 | 2021 | 220 | 0.170 |
Why?
|
| Spectrophotometry | 2 | 1997 | 309 | 0.170 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2021 | 234 | 0.170 |
Why?
|
| Nutrition Disorders | 1 | 2020 | 204 | 0.170 |
Why?
|
| Cranial Nerves | 1 | 2020 | 98 | 0.170 |
Why?
|
| Respiratory Function Tests | 2 | 2017 | 1683 | 0.170 |
Why?
|
| Allopurinol | 1 | 2021 | 198 | 0.170 |
Why?
|
| Scientific Misconduct | 2 | 2012 | 74 | 0.170 |
Why?
|
| Food | 1 | 2024 | 768 | 0.170 |
Why?
|
| Tetrazoles | 3 | 2015 | 909 | 0.160 |
Why?
|
| Drug Synergism | 9 | 2007 | 1756 | 0.160 |
Why?
|
| Bone Marrow Examination | 1 | 2019 | 155 | 0.160 |
Why?
|
| Mass Spectrometry | 5 | 2005 | 2189 | 0.160 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2008 | 2292 | 0.160 |
Why?
|
| Holistic Health | 1 | 2019 | 48 | 0.160 |
Why?
|
| Fetal Hypoxia | 1 | 2019 | 30 | 0.160 |
Why?
|
| Vomiting | 2 | 2013 | 651 | 0.160 |
Why?
|
| Ouabain | 1 | 2019 | 247 | 0.160 |
Why?
|
| Clavicle | 1 | 2021 | 224 | 0.160 |
Why?
|
| Treatment Outcome | 20 | 2021 | 64572 | 0.160 |
Why?
|
| Blood Coagulation | 8 | 2006 | 1154 | 0.160 |
Why?
|
| Amino Acid Chloromethyl Ketones | 3 | 1993 | 68 | 0.160 |
Why?
|
| Cholesterol Esters | 3 | 2005 | 73 | 0.160 |
Why?
|
| Ceftriaxone | 1 | 2020 | 175 | 0.160 |
Why?
|
| Phosphoproteins | 3 | 2018 | 2445 | 0.160 |
Why?
|
| Risk | 4 | 2016 | 9603 | 0.160 |
Why?
|
| Rickettsia typhi | 1 | 2018 | 5 | 0.160 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2019 | 2234 | 0.160 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2018 | 14 | 0.160 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2013 | 1650 | 0.160 |
Why?
|
| Oxidative Phosphorylation | 1 | 2021 | 495 | 0.160 |
Why?
|
| West Nile virus | 1 | 2019 | 77 | 0.160 |
Why?
|
| Receptors, Thrombin | 1 | 1999 | 130 | 0.160 |
Why?
|
| Ventricular Dysfunction, Right | 3 | 2021 | 628 | 0.160 |
Why?
|
| Ventricular Remodeling | 3 | 2021 | 1265 | 0.160 |
Why?
|
| Ticlopidine | 2 | 2006 | 730 | 0.160 |
Why?
|
| Superoxide Dismutase | 4 | 2005 | 593 | 0.160 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2019 | 129 | 0.160 |
Why?
|
| Leukocytosis | 1 | 2020 | 251 | 0.160 |
Why?
|
| American Heart Association | 4 | 2018 | 1039 | 0.160 |
Why?
|
| Hypocalcemia | 1 | 2020 | 200 | 0.160 |
Why?
|
| Paraneoplastic Syndromes | 1 | 2020 | 155 | 0.160 |
Why?
|
| Patient Care Team | 1 | 2010 | 2515 | 0.160 |
Why?
|
| Cell Movement | 7 | 2021 | 5201 | 0.160 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2019 | 12143 | 0.160 |
Why?
|
| Research | 3 | 2020 | 1977 | 0.160 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2020 | 361 | 0.160 |
Why?
|
| History, 21st Century | 2 | 2015 | 1566 | 0.160 |
Why?
|
| Disease Vectors | 1 | 2018 | 61 | 0.160 |
Why?
|
| Budesonide | 1 | 2019 | 157 | 0.160 |
Why?
|
| Mexico | 1 | 2021 | 757 | 0.160 |
Why?
|
| Artificial Intelligence | 2 | 2024 | 2575 | 0.160 |
Why?
|
| Interleukin-1 | 3 | 2005 | 1248 | 0.160 |
Why?
|
| Heart Valve Prosthesis Implantation | 2 | 2019 | 1553 | 0.150 |
Why?
|
| Athletes | 2 | 2016 | 1137 | 0.150 |
Why?
|
| Angina Pectoris | 4 | 2015 | 959 | 0.150 |
Why?
|
| Professional Competence | 2 | 2014 | 431 | 0.150 |
Why?
|
| Ventricular Function, Right | 2 | 2021 | 617 | 0.150 |
Why?
|
| Carcinoma, Ductal | 1 | 2019 | 97 | 0.150 |
Why?
|
| Methylene Blue | 3 | 1994 | 155 | 0.150 |
Why?
|
| Thromboplastin | 1 | 2000 | 286 | 0.150 |
Why?
|
| Patient Selection | 3 | 2021 | 4237 | 0.150 |
Why?
|
| Cell Division | 10 | 2004 | 4457 | 0.150 |
Why?
|
| Up-Regulation | 5 | 2016 | 4117 | 0.150 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2019 | 161 | 0.150 |
Why?
|
| Nitrites | 4 | 2009 | 159 | 0.150 |
Why?
|
| Aptamers, Nucleotide | 1 | 2019 | 164 | 0.150 |
Why?
|
| Collagen Type III | 1 | 2018 | 91 | 0.150 |
Why?
|
| Education | 1 | 2021 | 534 | 0.150 |
Why?
|
| Bacterial Proteins | 1 | 2011 | 3842 | 0.150 |
Why?
|
| Anti-Glomerular Basement Membrane Disease | 1 | 2018 | 41 | 0.150 |
Why?
|
| Genome-Wide Association Study | 9 | 2020 | 12661 | 0.150 |
Why?
|
| Transfection | 5 | 2009 | 5765 | 0.150 |
Why?
|
| History, 19th Century | 2 | 2017 | 718 | 0.150 |
Why?
|
| Hyperuricemia | 1 | 2021 | 222 | 0.150 |
Why?
|
| Deficiency Diseases | 2 | 2014 | 74 | 0.150 |
Why?
|
| Hypotension | 2 | 2013 | 879 | 0.150 |
Why?
|
| Research Report | 1 | 2021 | 367 | 0.150 |
Why?
|
| Herpesvirus 2, Human | 1 | 2019 | 191 | 0.150 |
Why?
|
| Internationality | 2 | 2020 | 1000 | 0.150 |
Why?
|
| Classification | 1 | 2018 | 127 | 0.150 |
Why?
|
| Cardiology Service, Hospital | 1 | 2019 | 239 | 0.150 |
Why?
|
| Lymphatic Metastasis | 2 | 2019 | 2913 | 0.150 |
Why?
|
| Cytosol | 3 | 2016 | 886 | 0.150 |
Why?
|
| Transaminases | 1 | 2018 | 199 | 0.150 |
Why?
|
| Drug Administration Routes | 1 | 2017 | 150 | 0.150 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 6 | 2004 | 1738 | 0.150 |
Why?
|
| Communication Barriers | 1 | 2021 | 414 | 0.150 |
Why?
|
| Proteins | 4 | 2007 | 6030 | 0.140 |
Why?
|
| Carbamazepine | 1 | 2018 | 224 | 0.140 |
Why?
|
| Anti-Arrhythmia Agents | 2 | 2013 | 763 | 0.140 |
Why?
|
| Antibodies, Fungal | 1 | 2017 | 34 | 0.140 |
Why?
|
| Troponin | 1 | 2021 | 502 | 0.140 |
Why?
|
| Microsomes, Liver | 1 | 1997 | 173 | 0.140 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2020 | 237 | 0.140 |
Why?
|
| Vena Cava, Superior | 1 | 2018 | 194 | 0.140 |
Why?
|
| Mental Disorders | 1 | 2017 | 6826 | 0.140 |
Why?
|
| Texas | 1 | 2018 | 403 | 0.140 |
Why?
|
| Syndrome | 5 | 2018 | 3268 | 0.140 |
Why?
|
| Rats, Sprague-Dawley | 13 | 2018 | 8165 | 0.140 |
Why?
|
| Health Care Reform | 2 | 2020 | 1247 | 0.140 |
Why?
|
| RNA, Transfer, Amino Acyl | 2 | 2014 | 46 | 0.140 |
Why?
|
| Blood Substitutes | 1 | 1997 | 57 | 0.140 |
Why?
|
| Sodium Chloride | 1 | 1999 | 586 | 0.140 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 2 | 2012 | 276 | 0.140 |
Why?
|
| Erythrocyte Transfusion | 2 | 2001 | 568 | 0.140 |
Why?
|
| Retinal Degeneration | 1 | 2021 | 414 | 0.140 |
Why?
|
| Serine | 1 | 2021 | 830 | 0.140 |
Why?
|
| Protein Disulfide-Isomerases | 1 | 1999 | 208 | 0.140 |
Why?
|
| Fibrinopeptide A | 1 | 1996 | 43 | 0.140 |
Why?
|
| Comorbidity | 5 | 2018 | 10507 | 0.140 |
Why?
|
| Heterozygote | 6 | 2009 | 2780 | 0.140 |
Why?
|
| International Educational Exchange | 1 | 2017 | 49 | 0.140 |
Why?
|
| Diffusion | 1 | 2018 | 814 | 0.140 |
Why?
|
| Saphenous Vein | 1 | 2000 | 516 | 0.140 |
Why?
|
| Anastomosis, Roux-en-Y | 1 | 2017 | 86 | 0.140 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2020 | 269 | 0.140 |
Why?
|
| NADPH Dehydrogenase | 2 | 1995 | 44 | 0.140 |
Why?
|
| Sodium Nitrite | 1 | 1996 | 16 | 0.140 |
Why?
|
| Hemodynamics | 8 | 2022 | 4160 | 0.140 |
Why?
|
| Cyclic AMP | 7 | 2007 | 1463 | 0.140 |
Why?
|
| Luminescent Measurements | 5 | 1997 | 340 | 0.140 |
Why?
|
| Hydronephrosis | 1 | 2018 | 271 | 0.140 |
Why?
|
| Molecular Sequence Data | 8 | 2014 | 17630 | 0.130 |
Why?
|
| Peroxynitrous Acid | 3 | 2019 | 40 | 0.130 |
Why?
|
| Coronary Artery Bypass | 2 | 2017 | 2188 | 0.130 |
Why?
|
| Lung Diseases, Fungal | 1 | 2017 | 125 | 0.130 |
Why?
|
| Lupus Coagulation Inhibitor | 1 | 2016 | 32 | 0.130 |
Why?
|
| Intracellular Space | 1 | 2017 | 197 | 0.130 |
Why?
|
| Mitogen-Activated Protein Kinase Phosphatases | 2 | 2013 | 47 | 0.130 |
Why?
|
| Renin-Angiotensin System | 1 | 2021 | 737 | 0.130 |
Why?
|
| Aged, 80 and over | 12 | 2019 | 58919 | 0.130 |
Why?
|
| DNA, Complementary | 3 | 2005 | 1989 | 0.130 |
Why?
|
| Histones | 2 | 2021 | 2577 | 0.130 |
Why?
|
| Pregnancy Trimester, First | 2 | 2020 | 908 | 0.130 |
Why?
|
| Doxycycline | 1 | 2018 | 344 | 0.130 |
Why?
|
| Young Adult | 14 | 2021 | 59191 | 0.130 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2018 | 755 | 0.130 |
Why?
|
| Pneumonia | 2 | 2019 | 2143 | 0.130 |
Why?
|
| Foreign Medical Graduates | 1 | 2017 | 77 | 0.130 |
Why?
|
| Antigens, CD | 2 | 2005 | 3998 | 0.130 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2022 | 1117 | 0.130 |
Why?
|
| Dual-Specificity Phosphatases | 2 | 2013 | 71 | 0.130 |
Why?
|
| Foot | 1 | 2020 | 575 | 0.130 |
Why?
|
| Electrophoresis | 2 | 1996 | 226 | 0.130 |
Why?
|
| Macrophage-1 Antigen | 2 | 1994 | 285 | 0.130 |
Why?
|
| Databases, Protein | 1 | 2018 | 387 | 0.130 |
Why?
|
| Diabetes Complications | 2 | 2002 | 1315 | 0.130 |
Why?
|
| Sequence Analysis, DNA | 4 | 2018 | 4739 | 0.130 |
Why?
|
| Endoscopy, Gastrointestinal | 2 | 2013 | 875 | 0.130 |
Why?
|
| Methacholine Chloride | 5 | 2003 | 220 | 0.130 |
Why?
|
| Models, Statistical | 2 | 2016 | 5074 | 0.130 |
Why?
|
| Herpes Simplex | 1 | 2019 | 465 | 0.130 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2016 | 11735 | 0.130 |
Why?
|
| Gene Frequency | 4 | 2016 | 3601 | 0.130 |
Why?
|
| Enzyme Induction | 3 | 2005 | 452 | 0.130 |
Why?
|
| Leukocytes, Mononuclear | 3 | 2022 | 1834 | 0.130 |
Why?
|
| Hyperemia | 2 | 2009 | 221 | 0.130 |
Why?
|
| Macrophages | 5 | 2020 | 5758 | 0.130 |
Why?
|
| Immune System | 1 | 2021 | 791 | 0.130 |
Why?
|
| Pneumonia, Bacterial | 1 | 2018 | 315 | 0.130 |
Why?
|
| Coronary Vasospasm | 1 | 2016 | 81 | 0.130 |
Why?
|
| Lupus Nephritis | 1 | 2019 | 317 | 0.130 |
Why?
|
| Oligonucleotides, Antisense | 4 | 2003 | 458 | 0.130 |
Why?
|
| Tremor | 1 | 2016 | 190 | 0.130 |
Why?
|
| Case-Control Studies | 9 | 2021 | 22153 | 0.130 |
Why?
|
| Photolysis | 4 | 1997 | 94 | 0.130 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2014 | 2495 | 0.130 |
Why?
|
| Antigens, Fungal | 1 | 2015 | 69 | 0.130 |
Why?
|
| Peptic Ulcer | 1 | 2017 | 217 | 0.130 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2016 | 118 | 0.120 |
Why?
|
| Pleural Effusion | 1 | 2018 | 341 | 0.120 |
Why?
|
| Stroke Volume | 6 | 2021 | 5486 | 0.120 |
Why?
|
| Fibroblasts | 5 | 2018 | 4140 | 0.120 |
Why?
|
| Polysaccharides | 2 | 2013 | 1013 | 0.120 |
Why?
|
| Sulfonamides | 4 | 2012 | 1977 | 0.120 |
Why?
|
| Stem Cell Transplantation | 3 | 2012 | 1600 | 0.120 |
Why?
|
| 3' Untranslated Regions | 2 | 2009 | 516 | 0.120 |
Why?
|
| Transcription, Genetic | 6 | 2019 | 7583 | 0.120 |
Why?
|
| Receptors, Cell Surface | 4 | 1994 | 2802 | 0.120 |
Why?
|
| Vascular Endothelial Growth Factor A | 7 | 2016 | 3492 | 0.120 |
Why?
|
| Autoantibodies | 2 | 2016 | 2115 | 0.120 |
Why?
|
| Protein Conformation | 8 | 2017 | 3965 | 0.120 |
Why?
|
| Genetic Markers | 3 | 2007 | 2601 | 0.120 |
Why?
|
| Antibodies, Bacterial | 1 | 2021 | 1464 | 0.120 |
Why?
|
| Alkalosis, Respiratory | 1 | 2014 | 20 | 0.120 |
Why?
|
| Amino Acid Sequence | 8 | 2014 | 13442 | 0.120 |
Why?
|
| Caveolin 1 | 1 | 2016 | 255 | 0.120 |
Why?
|
| Rats, Inbred Dahl | 4 | 2003 | 34 | 0.120 |
Why?
|
| Binding, Competitive | 6 | 1994 | 1141 | 0.120 |
Why?
|
| Genetic Testing | 4 | 2019 | 3533 | 0.120 |
Why?
|
| Mediastinal Diseases | 1 | 2015 | 91 | 0.120 |
Why?
|
| Multifactorial Inheritance | 1 | 2003 | 1381 | 0.120 |
Why?
|
| Catalysis | 4 | 2003 | 773 | 0.120 |
Why?
|
| Random Allocation | 4 | 2014 | 2392 | 0.120 |
Why?
|
| Carbon Dioxide | 1 | 2019 | 1148 | 0.120 |
Why?
|
| Sheep Diseases | 1 | 2014 | 17 | 0.120 |
Why?
|
| Causality | 1 | 2021 | 1241 | 0.120 |
Why?
|
| Fluorescent Dyes | 3 | 2019 | 1901 | 0.120 |
Why?
|
| Drug Therapy, Computer-Assisted | 1 | 2016 | 197 | 0.120 |
Why?
|
| MAP Kinase Signaling System | 2 | 2011 | 1483 | 0.120 |
Why?
|
| Atrial Fibrillation | 1 | 2013 | 5031 | 0.120 |
Why?
|
| Mice, Mutant Strains | 5 | 2009 | 1748 | 0.120 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2019 | 574 | 0.120 |
Why?
|
| Anemia | 2 | 2001 | 1504 | 0.120 |
Why?
|
| Cathepsin D | 1 | 1994 | 59 | 0.120 |
Why?
|
| Medical Errors | 2 | 2014 | 1263 | 0.120 |
Why?
|
| Fluoroscopy | 1 | 2018 | 945 | 0.120 |
Why?
|
| Angioplasty, Balloon, Coronary | 3 | 1996 | 1723 | 0.120 |
Why?
|
| Hep G2 Cells | 1 | 2015 | 378 | 0.120 |
Why?
|
| Conflict of Interest | 3 | 2008 | 554 | 0.120 |
Why?
|
| Emigrants and Immigrants | 1 | 2021 | 544 | 0.120 |
Why?
|
| Enterovirus B, Human | 1 | 2014 | 47 | 0.120 |
Why?
|
| Epigenomics | 3 | 2020 | 942 | 0.120 |
Why?
|
| Dipeptides | 1 | 1996 | 391 | 0.110 |
Why?
|
| Cholesterol, LDL | 4 | 2014 | 2378 | 0.110 |
Why?
|
| Diagnostic Errors | 1 | 2021 | 1265 | 0.110 |
Why?
|
| Hydroxychloroquine | 1 | 2018 | 426 | 0.110 |
Why?
|
| Electron Transport Chain Complex Proteins | 1 | 2014 | 38 | 0.110 |
Why?
|
| Cyclosporins | 2 | 1991 | 216 | 0.110 |
Why?
|
| Heart Failure, Systolic | 1 | 2015 | 135 | 0.110 |
Why?
|
| Cytoplasm | 1 | 2018 | 1503 | 0.110 |
Why?
|
| Parasitemia | 1 | 2014 | 165 | 0.110 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2019 | 610 | 0.110 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2016 | 582 | 0.110 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2017 | 410 | 0.110 |
Why?
|
| Vitamin B Deficiency | 1 | 2013 | 12 | 0.110 |
Why?
|
| Debridement | 1 | 2016 | 493 | 0.110 |
Why?
|
| Early Diagnosis | 1 | 2019 | 1185 | 0.110 |
Why?
|
| False Positive Reactions | 1 | 2016 | 957 | 0.110 |
Why?
|
| Emigration and Immigration | 1 | 2017 | 397 | 0.110 |
Why?
|
| Microcirculation | 4 | 2004 | 1272 | 0.110 |
Why?
|
| Blister | 1 | 2014 | 86 | 0.110 |
Why?
|
| Antistreptolysin | 1 | 2013 | 6 | 0.110 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 15250 | 0.110 |
Why?
|
| DNA Methylation | 4 | 2023 | 4392 | 0.110 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2016 | 1333 | 0.110 |
Why?
|
| Vitamin D | 4 | 2023 | 3301 | 0.110 |
Why?
|
| Enzyme Precursors | 2 | 1995 | 170 | 0.110 |
Why?
|
| Information Services | 1 | 2015 | 236 | 0.110 |
Why?
|
| Government Programs | 1 | 2016 | 278 | 0.110 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2014 | 96 | 0.110 |
Why?
|
| Digestive System Diseases | 1 | 2015 | 151 | 0.110 |
Why?
|
| Femoral Artery | 2 | 1995 | 826 | 0.110 |
Why?
|
| Troponin I | 1 | 2018 | 650 | 0.110 |
Why?
|
| Intention to Treat Analysis | 1 | 2014 | 413 | 0.110 |
Why?
|
| Colon | 2 | 2013 | 1791 | 0.110 |
Why?
|
| Calcium | 4 | 2004 | 5717 | 0.110 |
Why?
|
| Cerebrospinal Fluid | 1 | 2016 | 544 | 0.110 |
Why?
|
| Allostasis | 1 | 2014 | 72 | 0.110 |
Why?
|
| Mice, Transgenic | 8 | 2024 | 9526 | 0.110 |
Why?
|
| Peptide Hydrolases | 1 | 1996 | 624 | 0.110 |
Why?
|
| Phenylpropionates | 1 | 2013 | 35 | 0.110 |
Why?
|
| Caspase 3 | 2 | 2009 | 731 | 0.110 |
Why?
|
| Polypharmacy | 1 | 2016 | 306 | 0.110 |
Why?
|
| Adenoviridae | 3 | 2009 | 1084 | 0.110 |
Why?
|
| Nose Neoplasms | 1 | 2015 | 249 | 0.110 |
Why?
|
| Brachial Artery | 4 | 2009 | 366 | 0.110 |
Why?
|
| Hepatitis B Core Antigens | 1 | 2013 | 90 | 0.110 |
Why?
|
| Chloroquine | 1 | 2014 | 275 | 0.110 |
Why?
|
| Acetaminophen | 1 | 1997 | 555 | 0.110 |
Why?
|
| Luciferases | 2 | 2005 | 712 | 0.110 |
Why?
|
| Skin Tests | 1 | 2015 | 637 | 0.110 |
Why?
|
| Muscle Relaxation | 4 | 1994 | 138 | 0.110 |
Why?
|
| Plasma | 1 | 2016 | 586 | 0.110 |
Why?
|
| Blood Sedimentation | 1 | 2014 | 235 | 0.100 |
Why?
|
| Hyponatremia | 1 | 2015 | 279 | 0.100 |
Why?
|
| Sleep | 1 | 2009 | 4764 | 0.100 |
Why?
|
| Rocky Mountain Spotted Fever | 1 | 2012 | 19 | 0.100 |
Why?
|
| Respiratory Insufficiency | 1 | 2021 | 1230 | 0.100 |
Why?
|
| Pregnancy | 7 | 2023 | 29869 | 0.100 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2015 | 717 | 0.100 |
Why?
|
| Exercise Tolerance | 1 | 2018 | 836 | 0.100 |
Why?
|
| Heptanoic Acids | 2 | 2012 | 344 | 0.100 |
Why?
|
| Chromatids | 1 | 2012 | 62 | 0.100 |
Why?
|
| Receptor, Endothelin B | 1 | 2012 | 46 | 0.100 |
Why?
|
| Diffusion of Innovation | 1 | 2017 | 729 | 0.100 |
Why?
|
| Time Factors | 21 | 2019 | 39908 | 0.100 |
Why?
|
| Gastritis, Hypertrophic | 1 | 2012 | 9 | 0.100 |
Why?
|
| Platelet Count | 4 | 2001 | 780 | 0.100 |
Why?
|
| Hemorheology | 1 | 2012 | 144 | 0.100 |
Why?
|
| Renal Dialysis | 2 | 2015 | 1795 | 0.100 |
Why?
|
| Biological Availability | 3 | 2007 | 389 | 0.100 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 5 | 1999 | 577 | 0.100 |
Why?
|
| International Normalized Ratio | 1 | 2014 | 381 | 0.100 |
Why?
|
| Hematopoiesis | 1 | 2001 | 2049 | 0.100 |
Why?
|
| Necrosis | 1 | 2016 | 1610 | 0.100 |
Why?
|
| Scoliosis | 1 | 2019 | 740 | 0.100 |
Why?
|
| Ageusia | 1 | 2012 | 18 | 0.100 |
Why?
|
| Laparotomy | 1 | 2014 | 456 | 0.100 |
Why?
|
| Lectins | 1 | 2014 | 489 | 0.100 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2023 | 2674 | 0.100 |
Why?
|
| Granuloma | 2 | 2010 | 327 | 0.100 |
Why?
|
| Capillary Permeability | 2 | 1995 | 773 | 0.100 |
Why?
|
| Learning Curve | 1 | 2014 | 230 | 0.100 |
Why?
|
| Point-of-Care Systems | 1 | 2021 | 1213 | 0.100 |
Why?
|
| Patient Admission | 1 | 2019 | 1365 | 0.100 |
Why?
|
| Iron | 4 | 2014 | 1790 | 0.100 |
Why?
|
| Tachycardia | 1 | 2014 | 597 | 0.100 |
Why?
|
| Adipokines | 1 | 2014 | 308 | 0.100 |
Why?
|
| NG-Nitroarginine Methyl Ester | 6 | 2009 | 260 | 0.100 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2018 | 1186 | 0.100 |
Why?
|
| Proteinuria | 1 | 2015 | 605 | 0.100 |
Why?
|
| Ventricular Dysfunction, Left | 4 | 2018 | 2118 | 0.100 |
Why?
|
| Models, Chemical | 1 | 2014 | 611 | 0.100 |
Why?
|
| Medicare Payment Advisory Commission | 1 | 2011 | 14 | 0.100 |
Why?
|
| Xanthine Oxidase | 2 | 2021 | 69 | 0.100 |
Why?
|
| Hyperaldosteronism | 2 | 2012 | 247 | 0.100 |
Why?
|
| Cardiac Output, Low | 1 | 2012 | 191 | 0.100 |
Why?
|
| Neural Conduction | 1 | 2013 | 441 | 0.100 |
Why?
|
| Spinal Cord | 1 | 2020 | 1807 | 0.100 |
Why?
|
| Faculty, Medical | 1 | 2020 | 1204 | 0.100 |
Why?
|
| Pelvic Bones | 1 | 2014 | 270 | 0.100 |
Why?
|
| Forced Expiratory Volume | 2 | 2018 | 1814 | 0.100 |
Why?
|
| Organ Specificity | 1 | 2016 | 1964 | 0.100 |
Why?
|
| Coronary Stenosis | 1 | 2017 | 794 | 0.100 |
Why?
|
| Codon, Nonsense | 1 | 2013 | 284 | 0.100 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2018 | 2252 | 0.100 |
Why?
|
| Longevity | 1 | 2019 | 1064 | 0.100 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2018 | 3204 | 0.100 |
Why?
|
| Multiple Myeloma | 1 | 2009 | 5144 | 0.100 |
Why?
|
| Liver Glycogen | 1 | 2011 | 35 | 0.100 |
Why?
|
| Fractional Flow Reserve, Myocardial | 1 | 2015 | 324 | 0.100 |
Why?
|
| Nonlinear Dynamics | 1 | 2014 | 491 | 0.100 |
Why?
|
| Pyridazines | 1 | 2013 | 201 | 0.100 |
Why?
|
| State Medicine | 1 | 2013 | 216 | 0.090 |
Why?
|
| Sheep | 1 | 2014 | 1436 | 0.090 |
Why?
|
| Neck | 1 | 2016 | 734 | 0.090 |
Why?
|
| Mitochondrial Proteins | 1 | 2017 | 974 | 0.090 |
Why?
|
| Binding Sites | 7 | 2004 | 6051 | 0.090 |
Why?
|
| Prospective Studies | 14 | 2024 | 54364 | 0.090 |
Why?
|
| Pyrimidines | 3 | 2012 | 3027 | 0.090 |
Why?
|
| Thromboxane B2 | 3 | 2001 | 143 | 0.090 |
Why?
|
| Placenta | 1 | 2020 | 1709 | 0.090 |
Why?
|
| Acetylcholine | 5 | 2000 | 629 | 0.090 |
Why?
|
| Radionuclide Imaging | 2 | 2013 | 1972 | 0.090 |
Why?
|
| Polymyalgia Rheumatica | 1 | 2011 | 52 | 0.090 |
Why?
|
| Cerebrovascular Disorders | 3 | 2006 | 1474 | 0.090 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2017 | 1133 | 0.090 |
Why?
|
| Lymphoma, Follicular | 1 | 2015 | 457 | 0.090 |
Why?
|
| Cell Culture Techniques | 1 | 2018 | 1662 | 0.090 |
Why?
|
| Chromosome Segregation | 1 | 2012 | 234 | 0.090 |
Why?
|
| Phosphatidylethanolamines | 1 | 2011 | 129 | 0.090 |
Why?
|
| Inflammasomes | 1 | 2016 | 526 | 0.090 |
Why?
|
| Poisson Distribution | 1 | 2012 | 504 | 0.090 |
Why?
|
| Apolipoproteins B | 1 | 2012 | 385 | 0.090 |
Why?
|
| F2-Isoprostanes | 2 | 2001 | 35 | 0.090 |
Why?
|
| Gene Transfer Techniques | 3 | 2007 | 1202 | 0.090 |
Why?
|
| Immunoglobulin E | 1 | 2017 | 1502 | 0.090 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2010 | 29 | 0.090 |
Why?
|
| Heart Transplantation | 3 | 2006 | 3233 | 0.090 |
Why?
|
| Genes, Reporter | 2 | 2005 | 1525 | 0.090 |
Why?
|
| Haplotypes | 2 | 2007 | 2713 | 0.090 |
Why?
|
| Thrombospondin 1 | 4 | 2007 | 257 | 0.090 |
Why?
|
| Quality Assurance, Health Care | 2 | 2011 | 2164 | 0.090 |
Why?
|
| Vitamin D Deficiency | 1 | 2020 | 1388 | 0.090 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 614 | 0.090 |
Why?
|
| Vitamins | 2 | 2013 | 1635 | 0.090 |
Why?
|
| Hospital Departments | 1 | 2011 | 134 | 0.090 |
Why?
|
| Muscle Development | 1 | 2012 | 259 | 0.090 |
Why?
|
| Endometritis | 1 | 2010 | 49 | 0.090 |
Why?
|
| Propensity Score | 1 | 2018 | 1912 | 0.090 |
Why?
|
| Stomach Ulcer | 1 | 2010 | 122 | 0.090 |
Why?
|
| Breast Neoplasms | 3 | 2019 | 20988 | 0.090 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2020 | 1405 | 0.090 |
Why?
|
| Thioredoxins | 1 | 2011 | 202 | 0.090 |
Why?
|
| Mastectomy | 1 | 2019 | 1817 | 0.090 |
Why?
|
| Dinoprost | 2 | 2001 | 139 | 0.090 |
Why?
|
| Sweating | 1 | 2011 | 155 | 0.090 |
Why?
|
| Aorta, Thoracic | 6 | 2002 | 1096 | 0.090 |
Why?
|
| Benzimidazoles | 2 | 2015 | 858 | 0.090 |
Why?
|
| Staphylococcus aureus | 1 | 2018 | 1457 | 0.090 |
Why?
|
| Mechanotransduction, Cellular | 2 | 2016 | 528 | 0.090 |
Why?
|
| Vitamin E | 4 | 2014 | 872 | 0.090 |
Why?
|
| Dogs | 9 | 1999 | 3837 | 0.090 |
Why?
|
| HEK293 Cells | 2 | 2020 | 4269 | 0.090 |
Why?
|
| DNA Damage | 1 | 2000 | 2445 | 0.090 |
Why?
|
| Lipids | 3 | 1991 | 3332 | 0.090 |
Why?
|
| Polyuria | 1 | 2010 | 37 | 0.090 |
Why?
|
| Acute Disease | 7 | 2013 | 7236 | 0.090 |
Why?
|
| DNA Primers | 2 | 2007 | 2817 | 0.090 |
Why?
|
| Muscle Weakness | 1 | 2013 | 412 | 0.090 |
Why?
|
| Software | 1 | 2024 | 4432 | 0.090 |
Why?
|
| Pulmonary Fibrosis | 1 | 2014 | 505 | 0.090 |
Why?
|
| Gingival Hemorrhage | 1 | 2009 | 49 | 0.090 |
Why?
|
| Enalapril | 2 | 1992 | 312 | 0.090 |
Why?
|
| Hematocrit | 3 | 2001 | 623 | 0.090 |
Why?
|
| Ataxia | 1 | 2012 | 306 | 0.090 |
Why?
|
| Aorta, Abdominal | 1 | 2013 | 625 | 0.090 |
Why?
|
| Caspase 7 | 1 | 2009 | 50 | 0.090 |
Why?
|
| Antifibrinolytic Agents | 1 | 1993 | 287 | 0.090 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 1990 | 540 | 0.090 |
Why?
|
| Dehydroepiandrosterone | 2 | 2001 | 258 | 0.090 |
Why?
|
| HIV Infections | 1 | 2016 | 17342 | 0.080 |
Why?
|
| Collagen | 7 | 2016 | 2634 | 0.080 |
Why?
|
| Cell Nucleus | 1 | 2018 | 2894 | 0.080 |
Why?
|
| Hypergammaglobulinemia | 1 | 2009 | 71 | 0.080 |
Why?
|
| Pulmonary Medicine | 1 | 2012 | 221 | 0.080 |
Why?
|
| Exercise | 3 | 2015 | 5886 | 0.080 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2012 | 507 | 0.080 |
Why?
|
| Annexin A2 | 1 | 2009 | 43 | 0.080 |
Why?
|
| Cholelithiasis | 1 | 2011 | 407 | 0.080 |
Why?
|
| Pancytopenia | 1 | 2010 | 102 | 0.080 |
Why?
|
| Xerostomia | 1 | 2010 | 94 | 0.080 |
Why?
|
| Extracellular Matrix | 2 | 2016 | 1718 | 0.080 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2011 | 382 | 0.080 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 1999 | 2863 | 0.080 |
Why?
|
| Protein Kinase C | 3 | 2009 | 1202 | 0.080 |
Why?
|
| Substrate Specificity | 3 | 2003 | 1790 | 0.080 |
Why?
|
| Multiprotein Complexes | 1 | 2016 | 1118 | 0.080 |
Why?
|
| Immunoglobulin Light Chains | 1 | 2010 | 285 | 0.080 |
Why?
|
| Prostaglandins | 1 | 1990 | 398 | 0.080 |
Why?
|
| Systems Integration | 1 | 2011 | 426 | 0.080 |
Why?
|
| Blood Circulation | 1 | 1990 | 248 | 0.080 |
Why?
|
| RNA | 1 | 2019 | 2713 | 0.080 |
Why?
|
| Staphylococcal Infections | 1 | 2018 | 1406 | 0.080 |
Why?
|
| Aortography | 1 | 2011 | 421 | 0.080 |
Why?
|
| Urination Disorders | 1 | 2010 | 238 | 0.080 |
Why?
|
| Organizational Objectives | 1 | 2011 | 426 | 0.080 |
Why?
|
| Feasibility Studies | 2 | 2019 | 5239 | 0.080 |
Why?
|
| Diabetes Insipidus | 1 | 2010 | 144 | 0.080 |
Why?
|
| Isoenzymes | 2 | 2008 | 1687 | 0.080 |
Why?
|
| Bone Marrow Cells | 3 | 2004 | 2409 | 0.080 |
Why?
|
| Ultrasonography, Interventional | 1 | 2017 | 1496 | 0.080 |
Why?
|
| Uncoupling Agents | 1 | 2009 | 46 | 0.080 |
Why?
|
| Antithrombins | 1 | 1992 | 292 | 0.080 |
Why?
|
| Postpartum Period | 1 | 2016 | 1178 | 0.080 |
Why?
|
| Thromboxane A2 | 2 | 2006 | 88 | 0.080 |
Why?
|
| High-Throughput Screening Assays | 1 | 2015 | 933 | 0.080 |
Why?
|
| Tryptases | 1 | 2010 | 176 | 0.080 |
Why?
|
| Selectins | 2 | 1999 | 101 | 0.080 |
Why?
|
| Selenomethionine | 1 | 2008 | 18 | 0.080 |
Why?
|
| Sodium Selenite | 1 | 2008 | 11 | 0.080 |
Why?
|
| Hypokalemia | 1 | 2010 | 153 | 0.080 |
Why?
|
| Hepatitis | 1 | 2011 | 228 | 0.080 |
Why?
|
| Echocardiography, Doppler | 1 | 2013 | 893 | 0.080 |
Why?
|
| Serum Albumin | 1 | 1992 | 673 | 0.080 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2012 | 485 | 0.080 |
Why?
|
| Organoselenium Compounds | 1 | 2008 | 21 | 0.080 |
Why?
|
| Blood Vessel Prosthesis | 2 | 2013 | 951 | 0.080 |
Why?
|
| Hydroxyurea | 1 | 2010 | 282 | 0.080 |
Why?
|
| Renal Insufficiency | 1 | 2015 | 808 | 0.080 |
Why?
|
| Transduction, Genetic | 2 | 2009 | 901 | 0.080 |
Why?
|
| Rats, Wistar | 2 | 2011 | 1848 | 0.080 |
Why?
|
| Statistics, Nonparametric | 1 | 2014 | 2851 | 0.080 |
Why?
|
| Chromosome Mapping | 1 | 2017 | 4611 | 0.080 |
Why?
|
| Electrophoretic Mobility Shift Assay | 2 | 2007 | 292 | 0.080 |
Why?
|
| Procollagen | 1 | 2009 | 187 | 0.080 |
Why?
|
| Celiac Artery | 1 | 1989 | 65 | 0.080 |
Why?
|
| Uric Acid | 2 | 2021 | 806 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-jun | 4 | 2017 | 287 | 0.080 |
Why?
|
| Thrombopoietin | 2 | 2001 | 226 | 0.080 |
Why?
|
| Myasthenia Gravis | 1 | 2011 | 214 | 0.080 |
Why?
|
| Alcoholism | 1 | 2019 | 1972 | 0.080 |
Why?
|
| Analysis of Variance | 5 | 2007 | 6223 | 0.080 |
Why?
|
| Toes | 1 | 2010 | 209 | 0.080 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2010 | 305 | 0.080 |
Why?
|
| Obesity | 4 | 2017 | 12934 | 0.080 |
Why?
|
| Angiotensin II | 3 | 2005 | 849 | 0.080 |
Why?
|
| Evidence-Based Medicine | 4 | 2016 | 3680 | 0.080 |
Why?
|
| RNA, Untranslated | 1 | 2012 | 456 | 0.080 |
Why?
|
| Reagent Strips | 1 | 2008 | 40 | 0.080 |
Why?
|
| Immunoblotting | 2 | 2007 | 1646 | 0.080 |
Why?
|
| Forearm | 4 | 2003 | 427 | 0.080 |
Why?
|
| Indomethacin | 4 | 2002 | 323 | 0.080 |
Why?
|
| Hemoglobinuria, Paroxysmal | 1 | 2009 | 94 | 0.080 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 3 | 1994 | 75 | 0.080 |
Why?
|
| Biological Factors | 1 | 1989 | 157 | 0.080 |
Why?
|
| Atrioventricular Block | 1 | 2010 | 132 | 0.080 |
Why?
|
| Urinalysis | 1 | 2010 | 368 | 0.080 |
Why?
|
| Aerobiosis | 1 | 2008 | 100 | 0.080 |
Why?
|
| Advisory Committees | 2 | 2002 | 787 | 0.080 |
Why?
|
| Aortic Valve | 1 | 2018 | 1955 | 0.080 |
Why?
|
| Urticaria | 1 | 2009 | 150 | 0.080 |
Why?
|
| United States Dept. of Health and Human Services | 2 | 2020 | 88 | 0.080 |
Why?
|
| Peer Review, Research | 2 | 2008 | 339 | 0.080 |
Why?
|
| Arachidonate 15-Lipoxygenase | 1 | 2008 | 84 | 0.080 |
Why?
|
| Arachidonate 12-Lipoxygenase | 1 | 2008 | 82 | 0.080 |
Why?
|
| Cell Death | 3 | 2012 | 1677 | 0.080 |
Why?
|
| Pyrroles | 2 | 2012 | 1125 | 0.080 |
Why?
|
| Hemolysis | 1 | 2010 | 415 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 2 | 2011 | 1608 | 0.070 |
Why?
|
| Internet | 2 | 2024 | 3094 | 0.070 |
Why?
|
| Physical Conditioning, Animal | 1 | 2011 | 366 | 0.070 |
Why?
|
| Positron-Emission Tomography | 2 | 2015 | 6483 | 0.070 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 1989 | 393 | 0.070 |
Why?
|
| Adolescent | 17 | 2019 | 88247 | 0.070 |
Why?
|
| Double-Blind Method | 11 | 2015 | 12333 | 0.070 |
Why?
|
| Colorimetry | 1 | 2008 | 150 | 0.070 |
Why?
|
| China | 1 | 2014 | 2374 | 0.070 |
Why?
|
| Linoleic Acids | 1 | 1987 | 39 | 0.070 |
Why?
|
| Antibodies, Anticardiolipin | 1 | 2007 | 62 | 0.070 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2020 | 3394 | 0.070 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2009 | 304 | 0.070 |
Why?
|
| Antimalarials | 1 | 2014 | 907 | 0.070 |
Why?
|
| Graft vs Host Disease | 1 | 2020 | 3026 | 0.070 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 2007 | 329 | 0.070 |
Why?
|
| Microscopy, Confocal | 1 | 2014 | 1970 | 0.070 |
Why?
|
| Triglycerides | 7 | 2016 | 2459 | 0.070 |
Why?
|
| Blotting, Northern | 2 | 2007 | 1545 | 0.070 |
Why?
|
| Lumbar Vertebrae | 1 | 2017 | 1874 | 0.070 |
Why?
|
| Researcher-Subject Relations | 1 | 2007 | 15 | 0.070 |
Why?
|
| Blotting, Western | 4 | 2010 | 5034 | 0.070 |
Why?
|
| Regional Blood Flow | 9 | 2009 | 1496 | 0.070 |
Why?
|
| bcl-2-Associated X Protein | 3 | 2009 | 282 | 0.070 |
Why?
|
| Jejunum | 1 | 2009 | 472 | 0.070 |
Why?
|
| Insulin | 5 | 2016 | 6593 | 0.070 |
Why?
|
| Alopecia | 1 | 2012 | 412 | 0.070 |
Why?
|
| Single-Cell Analysis | 1 | 2018 | 2447 | 0.070 |
Why?
|
| Intellectual Property | 1 | 2007 | 31 | 0.070 |
Why?
|
| Oleic Acids | 1 | 1987 | 72 | 0.070 |
Why?
|
| Drug Delivery Systems | 1 | 2018 | 2222 | 0.070 |
Why?
|
| Healthcare Disparities | 2 | 2020 | 3351 | 0.070 |
Why?
|
| Work Schedule Tolerance | 1 | 2011 | 552 | 0.070 |
Why?
|
| Lung Injury | 1 | 2012 | 422 | 0.070 |
Why?
|
| Infertility, Male | 1 | 2010 | 396 | 0.070 |
Why?
|
| Creatine | 1 | 2009 | 427 | 0.070 |
Why?
|
| Receptors, Transforming Growth Factor beta | 2 | 2008 | 302 | 0.070 |
Why?
|
| Heart-Assist Devices | 1 | 2018 | 1288 | 0.070 |
Why?
|
| Complement Activation | 1 | 2009 | 445 | 0.070 |
Why?
|
| Terbium | 1 | 1986 | 7 | 0.070 |
Why?
|
| Diabetes Mellitus | 4 | 2013 | 5838 | 0.070 |
Why?
|
| Down-Regulation | 4 | 2012 | 2916 | 0.070 |
Why?
|
| Genome | 1 | 2015 | 1737 | 0.070 |
Why?
|
| Drug Design | 1 | 2012 | 1045 | 0.070 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 2057 | 0.070 |
Why?
|
| Mutation, Missense | 2 | 2015 | 2570 | 0.070 |
Why?
|
| Drug Tolerance | 3 | 2001 | 367 | 0.070 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2014 | 955 | 0.070 |
Why?
|
| Guidelines as Topic | 2 | 2010 | 1386 | 0.070 |
Why?
|
| Quantitative Trait Loci | 2 | 2012 | 2112 | 0.070 |
Why?
|
| Chromatography, Gas | 1 | 2006 | 151 | 0.070 |
Why?
|
| Cyclic AMP Response Element Modulator | 1 | 2007 | 88 | 0.070 |
Why?
|
| Central Nervous System Diseases | 2 | 2009 | 521 | 0.070 |
Why?
|
| Professional Misconduct | 1 | 2007 | 73 | 0.070 |
Why?
|
| Nervous System Diseases | 1 | 2017 | 1662 | 0.070 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2019 | 2152 | 0.070 |
Why?
|
| Norepinephrine | 4 | 2001 | 898 | 0.070 |
Why?
|
| Pulmonary Emphysema | 1 | 2012 | 684 | 0.070 |
Why?
|
| Chronic Disease | 4 | 2012 | 9310 | 0.070 |
Why?
|
| Alleles | 3 | 2008 | 6861 | 0.070 |
Why?
|
| Factor XIIIa | 1 | 2006 | 10 | 0.070 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2019 | 2518 | 0.070 |
Why?
|
| Consumer Product Safety | 1 | 2007 | 122 | 0.070 |
Why?
|
| Factor XIII Deficiency | 1 | 2006 | 16 | 0.070 |
Why?
|
| Cross-Over Studies | 4 | 2015 | 2079 | 0.070 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 1991 | 536 | 0.070 |
Why?
|
| Amebicides | 1 | 2005 | 6 | 0.070 |
Why?
|
| Survival Analysis | 1 | 2019 | 10072 | 0.070 |
Why?
|
| Peripheral Arterial Disease | 1 | 2017 | 1271 | 0.070 |
Why?
|
| Biological Transport | 3 | 1999 | 2089 | 0.070 |
Why?
|
| Humeral Fractures | 1 | 2009 | 282 | 0.070 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2016 | 2872 | 0.070 |
Why?
|
| Proportional Hazards Models | 2 | 2018 | 12448 | 0.070 |
Why?
|
| Epidermal Growth Factor | 1 | 2009 | 699 | 0.070 |
Why?
|
| Calcification, Physiologic | 1 | 2006 | 170 | 0.070 |
Why?
|
| Severity of Illness Index | 6 | 2018 | 15829 | 0.060 |
Why?
|
| Quality Improvement | 2 | 2011 | 3801 | 0.060 |
Why?
|
| Circadian Rhythm | 2 | 2014 | 2569 | 0.060 |
Why?
|
| Transplantation, Heterotopic | 1 | 2006 | 174 | 0.060 |
Why?
|
| Logistic Models | 3 | 2007 | 13248 | 0.060 |
Why?
|
| Prevalence | 2 | 2019 | 15702 | 0.060 |
Why?
|
| Medical Staff, Hospital | 1 | 2010 | 601 | 0.060 |
Why?
|
| Patents as Topic | 1 | 2007 | 111 | 0.060 |
Why?
|
| Cytokines | 3 | 2001 | 7373 | 0.060 |
Why?
|
| Half-Life | 3 | 1993 | 650 | 0.060 |
Why?
|
| Insect Hormones | 2 | 1996 | 73 | 0.060 |
Why?
|
| Spectrometry, Fluorescence | 5 | 1988 | 685 | 0.060 |
Why?
|
| Chemical Phenomena | 4 | 1990 | 506 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2016 | 4569 | 0.060 |
Why?
|
| Teaching Rounds | 1 | 2010 | 276 | 0.060 |
Why?
|
| Albuminuria | 1 | 2009 | 655 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factors | 3 | 2003 | 748 | 0.060 |
Why?
|
| Endocarditis | 1 | 2010 | 348 | 0.060 |
Why?
|
| Tyrosine | 4 | 2006 | 1440 | 0.060 |
Why?
|
| Codon, Terminator | 1 | 2005 | 124 | 0.060 |
Why?
|
| Medical History Taking | 1 | 2009 | 773 | 0.060 |
Why?
|
| Meta-Analysis as Topic | 2 | 2015 | 1380 | 0.060 |
Why?
|
| Monocrotaline | 3 | 2013 | 26 | 0.060 |
Why?
|
| Mathematics | 4 | 1994 | 707 | 0.060 |
Why?
|
| Investments | 1 | 2007 | 147 | 0.060 |
Why?
|
| Nutrition Surveys | 1 | 2013 | 1725 | 0.060 |
Why?
|
| Bisoprolol | 1 | 2015 | 9 | 0.060 |
Why?
|
| Efficiency, Organizational | 1 | 2010 | 695 | 0.060 |
Why?
|
| Endoplasmic Reticulum | 1 | 2011 | 1132 | 0.060 |
Why?
|
| Appetite Depressants | 1 | 2006 | 108 | 0.060 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2007 | 219 | 0.060 |
Why?
|
| Electronic Health Records | 2 | 2020 | 4810 | 0.060 |
Why?
|
| RNA Interference | 1 | 2014 | 2829 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 3 | 2000 | 6126 | 0.060 |
Why?
|
| Hospitals, Teaching | 1 | 2010 | 1155 | 0.060 |
Why?
|
| Heart Septal Defects | 1 | 1986 | 190 | 0.060 |
Why?
|
| Models, Cardiovascular | 3 | 2003 | 981 | 0.060 |
Why?
|
| Organizations | 1 | 2006 | 171 | 0.060 |
Why?
|
| Platelet Activating Factor | 2 | 2002 | 143 | 0.060 |
Why?
|
| Vena Cava, Inferior | 1 | 2008 | 458 | 0.060 |
Why?
|
| Platelet Factor 4 | 1 | 1985 | 129 | 0.060 |
Why?
|
| Aortic Aneurysm, Abdominal | 2 | 2013 | 1228 | 0.060 |
Why?
|
| Ornithine | 1 | 2004 | 79 | 0.060 |
Why?
|
| Professional Practice | 1 | 2007 | 313 | 0.060 |
Why?
|
| Fetus | 2 | 2024 | 1862 | 0.060 |
Why?
|
| Pharmaceutical Vehicles | 1 | 1984 | 57 | 0.060 |
Why?
|
| Receptors, Purinergic P1 | 1 | 2005 | 108 | 0.060 |
Why?
|
| Ultrasonography | 3 | 2014 | 5965 | 0.060 |
Why?
|
| International Cooperation | 2 | 2008 | 1422 | 0.060 |
Why?
|
| Aldehyde Oxidoreductases | 1 | 2015 | 88 | 0.060 |
Why?
|
| Insulin Resistance | 2 | 2016 | 3954 | 0.060 |
Why?
|
| Amlodipine | 1 | 2015 | 84 | 0.060 |
Why?
|
| Cohort Studies | 6 | 2021 | 41464 | 0.060 |
Why?
|
| Hydrochlorothiazide | 1 | 2015 | 94 | 0.060 |
Why?
|
| Enzyme Inhibitors | 5 | 2004 | 3705 | 0.060 |
Why?
|
| Politics | 1 | 2011 | 813 | 0.060 |
Why?
|
| Infusions, Intravenous | 5 | 1995 | 2214 | 0.060 |
Why?
|
| Coagulation Protein Disorders | 1 | 2004 | 6 | 0.060 |
Why?
|
| Codes of Ethics | 1 | 2004 | 61 | 0.060 |
Why?
|
| Disease Outbreaks | 1 | 2014 | 1748 | 0.060 |
Why?
|
| Pennsylvania | 1 | 2006 | 612 | 0.060 |
Why?
|
| Base Sequence | 3 | 2010 | 12420 | 0.060 |
Why?
|
| Subcellular Fractions | 2 | 2003 | 531 | 0.060 |
Why?
|
| Hypoxanthines | 1 | 2024 | 35 | 0.060 |
Why?
|
| Models, Theoretical | 2 | 1994 | 3567 | 0.060 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2012 | 1084 | 0.060 |
Why?
|
| Insect Proteins | 2 | 1996 | 254 | 0.060 |
Why?
|
| Adjuvants, Pharmaceutic | 1 | 1994 | 48 | 0.060 |
Why?
|
| Amino Acid Substitution | 2 | 2014 | 1739 | 0.060 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2006 | 278 | 0.060 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2007 | 852 | 0.060 |
Why?
|
| Glutathione Transferase | 1 | 1986 | 565 | 0.060 |
Why?
|
| Systems Theory | 1 | 2004 | 57 | 0.060 |
Why?
|
| Inpatients | 2 | 2019 | 2545 | 0.060 |
Why?
|
| Intercellular Adhesion Molecule-1 | 3 | 2014 | 1128 | 0.060 |
Why?
|
| Drug Administration Schedule | 3 | 2015 | 4845 | 0.060 |
Why?
|
| Environmental Exposure | 1 | 2019 | 4483 | 0.060 |
Why?
|
| Codon | 1 | 2005 | 600 | 0.060 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 2005 | 3769 | 0.060 |
Why?
|
| Coronary Circulation | 3 | 2002 | 1569 | 0.060 |
Why?
|
| Confidentiality | 1 | 2008 | 608 | 0.060 |
Why?
|
| omega-N-Methylarginine | 4 | 2003 | 108 | 0.060 |
Why?
|
| Saliva | 1 | 2008 | 828 | 0.060 |
Why?
|
| Hormones | 1 | 2007 | 869 | 0.060 |
Why?
|
| Vascular Patency | 5 | 1997 | 911 | 0.060 |
Why?
|
| Environment | 2 | 2020 | 1123 | 0.060 |
Why?
|
| Transcription Initiation Site | 1 | 2004 | 187 | 0.060 |
Why?
|
| Chloride Channels | 1 | 2015 | 221 | 0.060 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2010 | 1085 | 0.060 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2013 | 1400 | 0.060 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2006 | 431 | 0.050 |
Why?
|
| Potassium, Dietary | 1 | 2003 | 103 | 0.050 |
Why?
|
| Actins | 3 | 1993 | 2051 | 0.050 |
Why?
|
| Finland | 1 | 2015 | 607 | 0.050 |
Why?
|
| Kidney Failure, Chronic | 2 | 2008 | 2474 | 0.050 |
Why?
|
| Organizational Policy | 2 | 2002 | 432 | 0.050 |
Why?
|
| Xanthine | 1 | 2003 | 11 | 0.050 |
Why?
|
| DNA-Binding Proteins | 3 | 2017 | 9586 | 0.050 |
Why?
|
| Cholesterol, Dietary | 2 | 1994 | 224 | 0.050 |
Why?
|
| Disease Progression | 4 | 2016 | 13495 | 0.050 |
Why?
|
| Biphenyl Compounds | 2 | 2015 | 1007 | 0.050 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2023 | 81 | 0.050 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 5 | 2015 | 3245 | 0.050 |
Why?
|
| Blood Glucose | 4 | 2016 | 6390 | 0.050 |
Why?
|
| Delivery of Health Care | 2 | 2020 | 5334 | 0.050 |
Why?
|
| Child | 11 | 2019 | 80089 | 0.050 |
Why?
|
| Phosphotransferases | 1 | 2004 | 303 | 0.050 |
Why?
|
| Physical Examination | 1 | 2009 | 1254 | 0.050 |
Why?
|
| Indicators and Reagents | 2 | 1996 | 460 | 0.050 |
Why?
|
| Losartan | 1 | 2015 | 263 | 0.050 |
Why?
|
| Absorptiometry, Photon | 1 | 2009 | 1738 | 0.050 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2015 | 244 | 0.050 |
Why?
|
| Structure-Activity Relationship | 3 | 1996 | 3074 | 0.050 |
Why?
|
| Mast Cells | 1 | 2010 | 1392 | 0.050 |
Why?
|
| Oxygen Consumption | 1 | 2009 | 1866 | 0.050 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 2 | 2001 | 477 | 0.050 |
Why?
|
| Dexamethasone | 1 | 2010 | 1946 | 0.050 |
Why?
|
| Tissue Distribution | 3 | 2016 | 2261 | 0.050 |
Why?
|
| Private Sector | 1 | 2006 | 394 | 0.050 |
Why?
|
| Carrier Proteins | 3 | 2021 | 4937 | 0.050 |
Why?
|
| alpha-Tocopherol | 1 | 2003 | 126 | 0.050 |
Why?
|
| Embolism | 1 | 1986 | 399 | 0.050 |
Why?
|
| Immunoassay | 1 | 2006 | 744 | 0.050 |
Why?
|
| Administration, Oral | 1 | 2011 | 4010 | 0.050 |
Why?
|
| Boston | 2 | 2019 | 9313 | 0.050 |
Why?
|
| Abdomen | 1 | 1989 | 1128 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2009 | 2456 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3088 | 0.050 |
Why?
|
| Heart Conduction System | 1 | 2008 | 992 | 0.050 |
Why?
|
| Jurkat Cells | 2 | 2015 | 740 | 0.050 |
Why?
|
| Hydralazine | 1 | 2002 | 34 | 0.050 |
Why?
|
| Administration, Inhalation | 2 | 2004 | 1156 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3209 | 0.050 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 3 | 2011 | 691 | 0.050 |
Why?
|
| Isosorbide Dinitrate | 1 | 2002 | 34 | 0.050 |
Why?
|
| Endothelin-1 | 2 | 2015 | 302 | 0.050 |
Why?
|
| Fertilization in Vitro | 1 | 2010 | 1292 | 0.050 |
Why?
|
| Vision Disorders | 1 | 2010 | 1088 | 0.050 |
Why?
|
| Insulin-Secreting Cells | 1 | 2009 | 898 | 0.050 |
Why?
|
| Leukotrienes | 2 | 2002 | 231 | 0.050 |
Why?
|
| Glycosaminoglycans | 1 | 1985 | 607 | 0.050 |
Why?
|
| Muscarinic Agonists | 1 | 2002 | 91 | 0.050 |
Why?
|
| Heart Atria | 1 | 2008 | 1333 | 0.050 |
Why?
|
| Muscle, Smooth | 3 | 1996 | 927 | 0.050 |
Why?
|
| RNA-Binding Proteins | 2 | 2017 | 1890 | 0.050 |
Why?
|
| Thyroid Neoplasms | 1 | 2015 | 2332 | 0.050 |
Why?
|
| Hypolipidemic Agents | 2 | 1999 | 609 | 0.050 |
Why?
|
| Thiazolidines | 1 | 2002 | 69 | 0.050 |
Why?
|
| Chromogranin A | 1 | 2021 | 47 | 0.050 |
Why?
|
| Cell Aggregation | 1 | 2002 | 239 | 0.050 |
Why?
|
| Health Services Accessibility | 1 | 2019 | 5430 | 0.050 |
Why?
|
| Antitubercular Agents | 1 | 2010 | 1375 | 0.050 |
Why?
|
| Pyrrolidonecarboxylic Acid | 1 | 2002 | 65 | 0.050 |
Why?
|
| Amino Acid Transport Systems, Basic | 1 | 2001 | 33 | 0.050 |
Why?
|
| Heart Valve Prosthesis | 1 | 2010 | 1462 | 0.050 |
Why?
|
| Activin Receptors | 1 | 2001 | 40 | 0.050 |
Why?
|
| Serotonin | 2 | 2004 | 1041 | 0.050 |
Why?
|
| Splanchnic Circulation | 1 | 2002 | 119 | 0.050 |
Why?
|
| RNA, Transfer | 1 | 2004 | 289 | 0.050 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 2001 | 944 | 0.050 |
Why?
|
| Plateletpheresis | 1 | 2001 | 38 | 0.050 |
Why?
|
| Electrodes | 2 | 1996 | 610 | 0.050 |
Why?
|
| Oncostatin M | 1 | 2021 | 42 | 0.050 |
Why?
|
| Cytoprotection | 1 | 2002 | 200 | 0.050 |
Why?
|
| Ciliary Neurotrophic Factor | 1 | 2021 | 77 | 0.050 |
Why?
|
| Pteridines | 1 | 2001 | 47 | 0.050 |
Why?
|
| Renal Circulation | 2 | 2003 | 291 | 0.050 |
Why?
|
| Chemokines | 2 | 2020 | 954 | 0.050 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2010 | 2008 | 0.050 |
Why?
|
| Flow Cytometry | 5 | 2018 | 5863 | 0.050 |
Why?
|
| p-Aminohippuric Acid | 1 | 2001 | 36 | 0.050 |
Why?
|
| Circular Dichroism | 2 | 1996 | 344 | 0.050 |
Why?
|
| Rats, Mutant Strains | 1 | 2001 | 60 | 0.050 |
Why?
|
| Genetics, Medical | 1 | 2004 | 334 | 0.050 |
Why?
|
| Sulfones | 1 | 2004 | 447 | 0.050 |
Why?
|
| Endothelium | 1 | 2024 | 764 | 0.050 |
Why?
|
| Rupture, Spontaneous | 1 | 2002 | 362 | 0.050 |
Why?
|
| Candidiasis | 1 | 1984 | 365 | 0.050 |
Why?
|
| Glutathione Reductase | 1 | 2000 | 25 | 0.050 |
Why?
|
| Inulin | 1 | 2001 | 67 | 0.050 |
Why?
|
| Hyperglycemia | 1 | 2009 | 1375 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2001 | 174 | 0.050 |
Why?
|
| Carotid Artery Thrombosis | 1 | 2000 | 50 | 0.050 |
Why?
|
| Affinity Labels | 1 | 2000 | 107 | 0.050 |
Why?
|
| Glutamine | 1 | 2004 | 576 | 0.050 |
Why?
|
| Constriction, Pathologic | 3 | 1995 | 1096 | 0.050 |
Why?
|
| Heart Valves | 1 | 2002 | 284 | 0.050 |
Why?
|
| Oxypurinol | 1 | 2000 | 8 | 0.050 |
Why?
|
| Odds Ratio | 2 | 2004 | 9644 | 0.050 |
Why?
|
| Numerical Analysis, Computer-Assisted | 1 | 2020 | 119 | 0.050 |
Why?
|
| Thiazoles | 2 | 2002 | 1517 | 0.050 |
Why?
|
| Data Collection | 1 | 2010 | 3316 | 0.050 |
Why?
|
| United States Department of Agriculture | 1 | 2020 | 47 | 0.040 |
Why?
|
| Malates | 1 | 2020 | 34 | 0.040 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 2000 | 94 | 0.040 |
Why?
|
| Purines | 1 | 2004 | 606 | 0.040 |
Why?
|
| Disaccharides | 1 | 2001 | 170 | 0.040 |
Why?
|
| Intracellular Fluid | 1 | 2000 | 201 | 0.040 |
Why?
|
| Cerebral Veins | 1 | 2002 | 157 | 0.040 |
Why?
|
| Metabolic Clearance Rate | 1 | 2001 | 361 | 0.040 |
Why?
|
| Colitis, Ulcerative | 1 | 2012 | 1921 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 9277 | 0.040 |
Why?
|
| Blood Component Removal | 1 | 2001 | 132 | 0.040 |
Why?
|
| Angiotensin I | 2 | 1991 | 56 | 0.040 |
Why?
|
| Chemistry | 3 | 1990 | 346 | 0.040 |
Why?
|
| Bacteria | 1 | 2011 | 2192 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 2005 | 4172 | 0.040 |
Why?
|
| Vero Cells | 1 | 2021 | 481 | 0.040 |
Why?
|
| Hemoglobin SC Disease | 1 | 1999 | 22 | 0.040 |
Why?
|
| Xenopus laevis | 1 | 2004 | 963 | 0.040 |
Why?
|
| Pyruvates | 1 | 2019 | 83 | 0.040 |
Why?
|
| Rodentia | 1 | 2021 | 261 | 0.040 |
Why?
|
| Ubiquitins | 1 | 2001 | 366 | 0.040 |
Why?
|
| Amidines | 1 | 1999 | 29 | 0.040 |
Why?
|
| Valsalva Maneuver | 2 | 1992 | 98 | 0.040 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2015 | 4021 | 0.040 |
Why?
|
| Osteogenesis | 1 | 2006 | 1270 | 0.040 |
Why?
|
| Peroxides | 1 | 2019 | 74 | 0.040 |
Why?
|
| Thiazines | 1 | 1999 | 38 | 0.040 |
Why?
|
| Secondary Prevention | 1 | 2006 | 1470 | 0.040 |
Why?
|
| Microfilament Proteins | 1 | 2015 | 1130 | 0.040 |
Why?
|
| Observer Variation | 1 | 2005 | 2607 | 0.040 |
Why?
|
| Telangiectasia, Hereditary Hemorrhagic | 1 | 2001 | 141 | 0.040 |
Why?
|
| Receptor, erbB-2 | 1 | 2010 | 2553 | 0.040 |
Why?
|
| Raffinose | 1 | 1999 | 53 | 0.040 |
Why?
|
| Carotid Artery Diseases | 1 | 2005 | 877 | 0.040 |
Why?
|
| Cross-Linking Reagents | 2 | 2004 | 685 | 0.040 |
Why?
|
| Swine | 4 | 2002 | 5908 | 0.040 |
Why?
|
| Digestive System | 1 | 2000 | 244 | 0.040 |
Why?
|
| Cardiopulmonary Bypass | 2 | 1995 | 1092 | 0.040 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2000 | 613 | 0.040 |
Why?
|
| Gene Targeting | 1 | 2002 | 837 | 0.040 |
Why?
|
| Microscopy, Video | 1 | 1999 | 241 | 0.040 |
Why?
|
| Blood-Brain Barrier | 1 | 2005 | 1027 | 0.040 |
Why?
|
| Diet, Sodium-Restricted | 1 | 2001 | 291 | 0.040 |
Why?
|
| Review Literature as Topic | 1 | 2021 | 347 | 0.040 |
Why?
|
| Systole | 3 | 2006 | 935 | 0.040 |
Why?
|
| Immunophenotyping | 1 | 2023 | 1864 | 0.040 |
Why?
|
| Injections, Intravenous | 3 | 1996 | 1376 | 0.040 |
Why?
|
| Ventricular Function, Left | 3 | 2009 | 3873 | 0.040 |
Why?
|
| Cysteine Endopeptidases | 1 | 2001 | 552 | 0.040 |
Why?
|
| Calcimycin | 3 | 1994 | 213 | 0.040 |
Why?
|
| COP-Coated Vesicles | 1 | 2018 | 39 | 0.040 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2000 | 438 | 0.040 |
Why?
|
| Testosterone | 1 | 2009 | 2472 | 0.040 |
Why?
|
| Benzylamines | 1 | 1999 | 246 | 0.040 |
Why?
|
| E2F1 Transcription Factor | 1 | 2018 | 178 | 0.040 |
Why?
|
| Hypoglycemic Agents | 1 | 2011 | 3085 | 0.040 |
Why?
|
| Dobutamine | 2 | 1996 | 116 | 0.040 |
Why?
|
| Aminoimidazole Carboxamide | 1 | 2018 | 85 | 0.040 |
Why?
|
| Ribonucleotides | 1 | 2018 | 114 | 0.040 |
Why?
|
| Confidence Intervals | 1 | 2004 | 2925 | 0.040 |
Why?
|
| Shock, Septic | 2 | 1995 | 769 | 0.040 |
Why?
|
| Adenylate Kinase | 1 | 2018 | 102 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2006 | 4110 | 0.040 |
Why?
|
| Brazil | 1 | 2002 | 1229 | 0.040 |
Why?
|
| Mitochondria, Heart | 1 | 2019 | 229 | 0.040 |
Why?
|
| Starvation | 1 | 2018 | 141 | 0.040 |
Why?
|
| Aspartic Acid | 1 | 2020 | 576 | 0.040 |
Why?
|
| Fibroblast Growth Factor 2 | 2 | 2016 | 592 | 0.040 |
Why?
|
| Smad3 Protein | 1 | 2018 | 166 | 0.040 |
Why?
|
| Multienzyme Complexes | 1 | 2001 | 666 | 0.040 |
Why?
|
| Kidney Transplantation | 1 | 2013 | 4218 | 0.040 |
Why?
|
| Exercise Test | 2 | 2018 | 2127 | 0.040 |
Why?
|
| Curriculum | 1 | 2011 | 3739 | 0.040 |
Why?
|
| Sepharose | 1 | 1998 | 103 | 0.040 |
Why?
|
| Ion Channels | 1 | 2002 | 1039 | 0.040 |
Why?
|
| Papio | 2 | 1996 | 669 | 0.040 |
Why?
|
| Zebrafish | 2 | 2020 | 3005 | 0.040 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2020 | 730 | 0.040 |
Why?
|
| Oligochaeta | 1 | 1997 | 9 | 0.040 |
Why?
|
| Alcohol Drinking | 1 | 2010 | 4028 | 0.040 |
Why?
|
| Feedback | 1 | 2001 | 790 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2003 | 1404 | 0.040 |
Why?
|
| Depression, Chemical | 1 | 1997 | 184 | 0.040 |
Why?
|
| Patient Satisfaction | 1 | 2010 | 3451 | 0.040 |
Why?
|
| Second Messenger Systems | 2 | 1995 | 202 | 0.040 |
Why?
|
| Androstadienes | 1 | 1999 | 348 | 0.040 |
Why?
|
| Blood Viscosity | 1 | 1997 | 124 | 0.040 |
Why?
|
| Central Nervous System Stimulants | 1 | 2006 | 1177 | 0.040 |
Why?
|
| Urea | 1 | 1999 | 443 | 0.040 |
Why?
|
| Caspases | 1 | 2000 | 878 | 0.040 |
Why?
|
| Drug Carriers | 1 | 2021 | 706 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2011 | 476 | 0.030 |
Why?
|
| Coated Materials, Biocompatible | 1 | 1999 | 311 | 0.030 |
Why?
|
| Survival Rate | 5 | 2012 | 12719 | 0.030 |
Why?
|
| United States Food and Drug Administration | 1 | 2005 | 1661 | 0.030 |
Why?
|
| Fetal Blood | 1 | 2023 | 1347 | 0.030 |
Why?
|
| Thermus | 1 | 2016 | 10 | 0.030 |
Why?
|
| Protamines | 1 | 1997 | 112 | 0.030 |
Why?
|
| Antibodies, Viral | 1 | 1988 | 3149 | 0.030 |
Why?
|
| Spectrophotometry, Ultraviolet | 2 | 1988 | 201 | 0.030 |
Why?
|
| Vital Capacity | 1 | 2019 | 971 | 0.030 |
Why?
|
| Blood Volume | 1 | 1998 | 547 | 0.030 |
Why?
|
| Aldehyde Reductase | 1 | 2016 | 70 | 0.030 |
Why?
|
| Cations, Divalent | 1 | 1976 | 168 | 0.030 |
Why?
|
| Cricetulus | 1 | 2018 | 814 | 0.030 |
Why?
|
| Muramidase | 1 | 2016 | 167 | 0.030 |
Why?
|
| src-Family Kinases | 1 | 1999 | 535 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2018 | 550 | 0.030 |
Why?
|
| Health Status Disparities | 2 | 2019 | 1846 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2000 | 2747 | 0.030 |
Why?
|
| Health Care Costs | 2 | 2020 | 3238 | 0.030 |
Why?
|
| Length of Stay | 1 | 2010 | 6418 | 0.030 |
Why?
|
| Retinol-Binding Proteins, Plasma | 1 | 2016 | 94 | 0.030 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1997 | 411 | 0.030 |
Why?
|
| Islam | 1 | 2017 | 71 | 0.030 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 1995 | 100 | 0.030 |
Why?
|
| Animals, Newborn | 2 | 2006 | 2669 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2005 | 3392 | 0.030 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2016 | 103 | 0.030 |
Why?
|
| Electrolytes | 3 | 1999 | 274 | 0.030 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2017 | 296 | 0.030 |
Why?
|
| Indium Radioisotopes | 1 | 1995 | 113 | 0.030 |
Why?
|
| Bone Marrow Transplantation | 1 | 2004 | 2690 | 0.030 |
Why?
|
| Resistin | 1 | 2016 | 172 | 0.030 |
Why?
|
| Electrochemistry | 1 | 1996 | 145 | 0.030 |
Why?
|
| Early Growth Response Protein 1 | 2 | 2007 | 133 | 0.030 |
Why?
|
| Cell Communication | 1 | 2003 | 1654 | 0.030 |
Why?
|
| Phosphorylation | 3 | 2018 | 8311 | 0.030 |
Why?
|
| Autoimmunity | 1 | 2023 | 1350 | 0.030 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2016 | 274 | 0.030 |
Why?
|
| Molecular Weight | 3 | 1993 | 2185 | 0.030 |
Why?
|
| Rats, Inbred Lew | 1 | 1997 | 1157 | 0.030 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2009 | 1877 | 0.030 |
Why?
|
| Receptors, Mineralocorticoid | 1 | 2016 | 163 | 0.030 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2015 | 56 | 0.030 |
Why?
|
| GTPase-Activating Proteins | 1 | 2018 | 471 | 0.030 |
Why?
|
| Anistreplase | 1 | 1994 | 11 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2000 | 1242 | 0.030 |
Why?
|
| Retinal Ganglion Cells | 1 | 2021 | 810 | 0.030 |
Why?
|
| Chelating Agents | 1 | 1997 | 387 | 0.030 |
Why?
|
| Wound Healing | 2 | 2005 | 2802 | 0.030 |
Why?
|
| Biotransformation | 1 | 2015 | 166 | 0.030 |
Why?
|
| Adrenergic beta-Agonists | 1 | 1996 | 346 | 0.030 |
Why?
|
| Sphincter of Oddi | 1 | 1994 | 21 | 0.030 |
Why?
|
| Primary Prevention | 1 | 2002 | 1185 | 0.030 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 1997 | 412 | 0.030 |
Why?
|
| Anemia, Sickle Cell | 1 | 2003 | 1061 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2001 | 1320 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2010 | 4325 | 0.030 |
Why?
|
| Cathepsins | 1 | 1996 | 241 | 0.030 |
Why?
|
| Integrins | 1 | 1999 | 834 | 0.030 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2015 | 126 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2003 | 14649 | 0.030 |
Why?
|
| Recurrence | 3 | 1995 | 8426 | 0.030 |
Why?
|
| RNA, Transfer, Ser | 1 | 2014 | 7 | 0.030 |
Why?
|
| Brain Diseases | 1 | 1984 | 1546 | 0.030 |
Why?
|
| Cognition Disorders | 1 | 2009 | 3979 | 0.030 |
Why?
|
| Human Genome Project | 1 | 2015 | 200 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2004 | 6074 | 0.030 |
Why?
|
| Genetics | 1 | 2015 | 114 | 0.030 |
Why?
|
| Angioplasty, Balloon, Laser-Assisted | 1 | 1994 | 20 | 0.030 |
Why?
|
| Environmental Pollutants | 1 | 2004 | 1277 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2019 | 1074 | 0.030 |
Why?
|
| Warfarin | 2 | 1993 | 1477 | 0.030 |
Why?
|
| Telomerase | 1 | 2019 | 744 | 0.030 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1996 | 618 | 0.030 |
Why?
|
| Follow-Up Studies | 8 | 2014 | 39062 | 0.030 |
Why?
|
| Reference Values | 2 | 2002 | 4919 | 0.030 |
Why?
|
| Carrageenan | 1 | 1994 | 71 | 0.030 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 1995 | 242 | 0.030 |
Why?
|
| Phospholipids | 2 | 2005 | 787 | 0.030 |
Why?
|
| Metabolic Diseases | 1 | 2020 | 680 | 0.030 |
Why?
|
| Umbilical Veins | 3 | 2004 | 426 | 0.030 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2000 | 1208 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2019 | 2063 | 0.030 |
Why?
|
| Microspheres | 1 | 1997 | 782 | 0.030 |
Why?
|
| Cytoskeletal Proteins | 1 | 2019 | 1336 | 0.030 |
Why?
|
| Viral Proteins | 1 | 2021 | 1799 | 0.030 |
Why?
|
| Foam Cells | 1 | 1994 | 68 | 0.030 |
Why?
|
| Caenorhabditis elegans | 1 | 2023 | 1452 | 0.030 |
Why?
|
| Carbohydrate Sequence | 2 | 1992 | 411 | 0.030 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2017 | 597 | 0.030 |
Why?
|
| Salivary Proteins and Peptides | 1 | 1993 | 48 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2001 | 1962 | 0.030 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2003 | 1241 | 0.030 |
Why?
|
| Cholesterol, HDL | 2 | 1991 | 1810 | 0.030 |
Why?
|
| Smoking | 3 | 2010 | 9054 | 0.030 |
Why?
|
| Hypertriglyceridemia | 1 | 2016 | 293 | 0.030 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 1995 | 156 | 0.030 |
Why?
|
| Tissue Extracts | 1 | 1993 | 139 | 0.030 |
Why?
|
| Chromatography, Gel | 1 | 1994 | 645 | 0.030 |
Why?
|
| Piperazines | 1 | 2004 | 2521 | 0.030 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 1994 | 186 | 0.030 |
Why?
|
| Drug Resistance | 1 | 1999 | 1594 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 2 | 2003 | 2174 | 0.030 |
Why?
|
| Myocardial Ischemia | 1 | 2004 | 2110 | 0.030 |
Why?
|
| Heart Rate | 3 | 2001 | 4181 | 0.030 |
Why?
|
| Neutropenia | 1 | 1998 | 885 | 0.030 |
Why?
|
| Carboxylic Acids | 1 | 1973 | 90 | 0.030 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 1993 | 179 | 0.030 |
Why?
|
| Isoprostanes | 1 | 2012 | 21 | 0.030 |
Why?
|
| Ascorbic Acid | 2 | 2009 | 655 | 0.030 |
Why?
|
| Temperature | 2 | 1993 | 2224 | 0.030 |
Why?
|
| Protein Transport | 2 | 2012 | 1966 | 0.030 |
Why?
|
| Massachusetts | 1 | 2006 | 8835 | 0.030 |
Why?
|
| Thromboxanes | 1 | 1992 | 45 | 0.030 |
Why?
|
| Health Priorities | 1 | 2016 | 375 | 0.030 |
Why?
|
| Calcium Channel Blockers | 2 | 1995 | 694 | 0.030 |
Why?
|
| Incidence | 3 | 2016 | 21339 | 0.030 |
Why?
|
| Gangliosides | 1 | 1993 | 132 | 0.030 |
Why?
|
| Potassium Channels | 2 | 1994 | 537 | 0.030 |
Why?
|
| Methods | 1 | 1992 | 1065 | 0.030 |
Why?
|
| Tyramine | 1 | 1992 | 53 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2018 | 3088 | 0.030 |
Why?
|
| Apolipoproteins A | 1 | 1992 | 95 | 0.030 |
Why?
|
| Electron Probe Microanalysis | 1 | 2011 | 32 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 13635 | 0.020 |
Why?
|
| Salivary Glands | 1 | 1993 | 229 | 0.020 |
Why?
|
| Bromodeoxyuridine | 1 | 2012 | 310 | 0.020 |
Why?
|
| Vagus Nerve | 1 | 1995 | 458 | 0.020 |
Why?
|
| Selenoprotein P | 1 | 2011 | 33 | 0.020 |
Why?
|
| Bayes Theorem | 1 | 2020 | 2327 | 0.020 |
Why?
|
| Lipoproteins, HDL | 1 | 2016 | 675 | 0.020 |
Why?
|
| Organ Size | 2 | 2009 | 2252 | 0.020 |
Why?
|
| Cystine | 1 | 1992 | 94 | 0.020 |
Why?
|
| DNA | 3 | 2012 | 7196 | 0.020 |
Why?
|
| Mole Rats | 1 | 2011 | 28 | 0.020 |
Why?
|
| Pipecolic Acids | 1 | 1992 | 77 | 0.020 |
Why?
|
| Chemotaxis | 1 | 2015 | 598 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2003 | 4512 | 0.020 |
Why?
|
| Pressure | 3 | 2008 | 1150 | 0.020 |
Why?
|
| Niacinamide | 1 | 1994 | 413 | 0.020 |
Why?
|
| Immunologic Techniques | 1 | 1992 | 212 | 0.020 |
Why?
|
| RNA, Transfer, Amino Acid-Specific | 1 | 2011 | 23 | 0.020 |
Why?
|
| Aging | 3 | 2020 | 8700 | 0.020 |
Why?
|
| Cell Separation | 2 | 1994 | 1718 | 0.020 |
Why?
|
| Cell Membrane Permeability | 1 | 1993 | 574 | 0.020 |
Why?
|
| Hypothalamus | 1 | 2016 | 999 | 0.020 |
Why?
|
| Rats, Inbred F344 | 1 | 2012 | 826 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 2002 | 3688 | 0.020 |
Why?
|
| Spectrometry, X-Ray Emission | 1 | 2011 | 143 | 0.020 |
Why?
|
| Polymers | 3 | 1987 | 1614 | 0.020 |
Why?
|
| Military Personnel | 1 | 2020 | 1245 | 0.020 |
Why?
|
| Neurotransmitter Agents | 1 | 2015 | 665 | 0.020 |
Why?
|
| Immune Sera | 1 | 1991 | 605 | 0.020 |
Why?
|
| Drosophila | 1 | 2018 | 1494 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2001 | 3205 | 0.020 |
Why?
|
| Aerosols | 1 | 2013 | 635 | 0.020 |
Why?
|
| Data Mining | 1 | 2016 | 551 | 0.020 |
Why?
|
| Basement Membrane | 1 | 2011 | 349 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 2016 | 1175 | 0.020 |
Why?
|
| Tranexamic Acid | 1 | 1993 | 172 | 0.020 |
Why?
|
| Carotenoids | 1 | 1993 | 621 | 0.020 |
Why?
|
| Cost of Illness | 1 | 2020 | 1937 | 0.020 |
Why?
|
| Particle Size | 1 | 2015 | 1648 | 0.020 |
Why?
|
| Autophagy | 1 | 2018 | 1327 | 0.020 |
Why?
|
| Formaldehyde | 2 | 1989 | 357 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 1991 | 659 | 0.020 |
Why?
|
| Blood Transfusion | 1 | 1997 | 1300 | 0.020 |
Why?
|
| Respiratory System | 1 | 1993 | 563 | 0.020 |
Why?
|
| Drug Costs | 1 | 1998 | 1183 | 0.020 |
Why?
|
| Retroperitoneal Space | 1 | 1990 | 170 | 0.020 |
Why?
|
| Cebus | 1 | 1989 | 15 | 0.020 |
Why?
|
| I-kappa B Kinase | 1 | 2011 | 249 | 0.020 |
Why?
|
| Bronchodilator Agents | 1 | 1993 | 512 | 0.020 |
Why?
|
| Bacteriocins | 1 | 2010 | 88 | 0.020 |
Why?
|
| Erythrocytes | 2 | 2010 | 2410 | 0.020 |
Why?
|
| Guinea Pigs | 3 | 2000 | 1310 | 0.020 |
Why?
|
| Epinephrine | 1 | 1993 | 792 | 0.020 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2015 | 395 | 0.020 |
Why?
|
| Blood Coagulation Disorders | 1 | 1993 | 350 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2011 | 472 | 0.020 |
Why?
|
| Microchemistry | 1 | 1989 | 54 | 0.020 |
Why?
|
| Sex Factors | 2 | 2009 | 10549 | 0.020 |
Why?
|
| Fixatives | 1 | 1989 | 90 | 0.020 |
Why?
|
| Bronchi | 1 | 1994 | 846 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2010 | 228 | 0.020 |
Why?
|
| Saralasin | 1 | 1989 | 34 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2022 | 4365 | 0.020 |
Why?
|
| Carbohydrates | 1 | 1992 | 390 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2000 | 2916 | 0.020 |
Why?
|
| Oligosaccharides | 1 | 1992 | 406 | 0.020 |
Why?
|
| Oligonucleotides | 1 | 2012 | 566 | 0.020 |
Why?
|
| Kidney Cortex | 1 | 2009 | 169 | 0.020 |
Why?
|
| S-Nitroso-N-Acetylpenicillamine | 1 | 2009 | 23 | 0.020 |
Why?
|
| Polystyrenes | 1 | 1989 | 104 | 0.020 |
Why?
|
| Adsorption | 1 | 1989 | 197 | 0.020 |
Why?
|
| Chemistry, Physical | 1 | 1989 | 154 | 0.020 |
Why?
|
| T-Lymphocytes | 2 | 2022 | 10175 | 0.020 |
Why?
|
| Neurons | 2 | 2002 | 9436 | 0.020 |
Why?
|
| DNA Probes | 1 | 2010 | 541 | 0.020 |
Why?
|
| Prazosin | 1 | 1989 | 95 | 0.020 |
Why?
|
| Complement Membrane Attack Complex | 1 | 2009 | 105 | 0.020 |
Why?
|
| Sodium Iodide | 1 | 1988 | 11 | 0.020 |
Why?
|
| Alzheimer Disease | 2 | 2019 | 8603 | 0.020 |
Why?
|
| Dyslipidemias | 1 | 2016 | 868 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2016 | 16968 | 0.020 |
Why?
|
| Immunization, Passive | 1 | 1991 | 616 | 0.020 |
Why?
|
| Albumins | 1 | 1991 | 575 | 0.020 |
Why?
|
| Microvessels | 1 | 2013 | 577 | 0.020 |
Why?
|
| I-kappa B Proteins | 1 | 2009 | 211 | 0.020 |
Why?
|
| Nutritional Status | 1 | 1997 | 1597 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2015 | 3606 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2021 | 3037 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2011 | 802 | 0.020 |
Why?
|
| Femoral Vein | 1 | 1989 | 153 | 0.020 |
Why?
|
| Protease Inhibitors | 1 | 1992 | 753 | 0.020 |
Why?
|
| Information Dissemination | 1 | 2017 | 1126 | 0.020 |
Why?
|
| S Phase | 2 | 2002 | 421 | 0.020 |
Why?
|
| Polylysine | 1 | 1988 | 131 | 0.020 |
Why?
|
| Cell Differentiation | 3 | 2018 | 11512 | 0.020 |
Why?
|
| Posture | 1 | 1992 | 956 | 0.020 |
Why?
|
| Lymphadenitis | 1 | 1989 | 99 | 0.020 |
Why?
|
| Stearates | 1 | 1987 | 6 | 0.020 |
Why?
|
| Puberty | 1 | 1991 | 501 | 0.020 |
Why?
|
| Jugular Veins | 1 | 1989 | 210 | 0.020 |
Why?
|
| Myocardial Reperfusion | 1 | 1989 | 338 | 0.020 |
Why?
|
| alpha-2-Antiplasmin | 1 | 1987 | 13 | 0.020 |
Why?
|
| Phagocytosis | 1 | 1993 | 1526 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2016 | 3730 | 0.020 |
Why?
|
| Fasting | 1 | 1994 | 1603 | 0.020 |
Why?
|
| Clone Cells | 1 | 2011 | 1657 | 0.020 |
Why?
|
| Models, Organizational | 1 | 2011 | 544 | 0.020 |
Why?
|
| Glycoproteins | 2 | 1986 | 2200 | 0.020 |
Why?
|
| Creatine Kinase | 1 | 2009 | 685 | 0.020 |
Why?
|
| Verapamil | 2 | 2002 | 242 | 0.020 |
Why?
|
| Oleic Acid | 1 | 1987 | 92 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2004 | 7390 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2011 | 727 | 0.020 |
Why?
|
| Delirium | 1 | 2019 | 1667 | 0.020 |
Why?
|
| Platelet Function Tests | 1 | 1989 | 271 | 0.020 |
Why?
|
| Propranolol | 1 | 1989 | 490 | 0.020 |
Why?
|
| Retrospective Studies | 4 | 2019 | 80583 | 0.020 |
Why?
|
| Complement C3 | 1 | 2009 | 434 | 0.020 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2010 | 540 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2017 | 5433 | 0.020 |
Why?
|
| Lanthanum | 1 | 1986 | 30 | 0.020 |
Why?
|
| Estradiol | 1 | 1994 | 1937 | 0.020 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 1992 | 1068 | 0.020 |
Why?
|
| Dinitrochlorobenzene | 1 | 1986 | 18 | 0.020 |
Why?
|
| Isoelectric Point | 1 | 1986 | 76 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2016 | 2851 | 0.020 |
Why?
|
| Apolipoproteins | 1 | 1989 | 326 | 0.020 |
Why?
|
| Nitrobenzenes | 1 | 1986 | 66 | 0.020 |
Why?
|
| Linoleic Acid | 1 | 1987 | 158 | 0.020 |
Why?
|
| Erythrocyte Deformability | 1 | 1986 | 55 | 0.020 |
Why?
|
| Iodine Radioisotopes | 1 | 1990 | 1031 | 0.020 |
Why?
|
| Diet, Atherogenic | 1 | 2006 | 92 | 0.020 |
Why?
|
| Telomere | 1 | 2012 | 942 | 0.020 |
Why?
|
| Evans Blue | 1 | 2005 | 42 | 0.020 |
Why?
|
| Prefrontal Cortex | 1 | 2016 | 2219 | 0.020 |
Why?
|
| Epoxy Compounds | 1 | 1986 | 137 | 0.020 |
Why?
|
| Drug Evaluation | 1 | 1987 | 641 | 0.020 |
Why?
|
| Nitrophenols | 1 | 1986 | 169 | 0.020 |
Why?
|
| Amino Acids | 1 | 1992 | 1718 | 0.020 |
Why?
|
| Factor X | 1 | 1985 | 64 | 0.020 |
Why?
|
| Endocytosis | 1 | 1990 | 955 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2019 | 3269 | 0.020 |
Why?
|
| Health | 1 | 2008 | 398 | 0.020 |
Why?
|
| Ear, External | 1 | 2006 | 165 | 0.020 |
Why?
|
| Hospitalization | 3 | 2018 | 10708 | 0.020 |
Why?
|
| Carboxypeptidases | 1 | 1985 | 155 | 0.020 |
Why?
|
| Diastole | 2 | 2003 | 781 | 0.020 |
Why?
|
| Radioligand Assay | 1 | 1985 | 366 | 0.020 |
Why?
|
| Colitis | 1 | 1993 | 1234 | 0.020 |
Why?
|
| Antigens | 1 | 1990 | 1441 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 2019 | 2878 | 0.020 |
Why?
|
| Propylene Glycol | 1 | 1984 | 30 | 0.020 |
Why?
|
| Diabetic Neuropathies | 1 | 1988 | 405 | 0.020 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2005 | 144 | 0.010 |
Why?
|
| Solubility | 1 | 1986 | 1089 | 0.010 |
Why?
|
| Solutions | 1 | 1985 | 412 | 0.010 |
Why?
|
| Homozygote | 1 | 2009 | 1776 | 0.010 |
Why?
|
| Genetic Engineering | 1 | 1990 | 931 | 0.010 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2013 | 1723 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2016 | 3310 | 0.010 |
Why?
|
| Propylene Glycols | 1 | 1984 | 91 | 0.010 |
Why?
|
| Laminin | 1 | 2006 | 408 | 0.010 |
Why?
|
| Infusions, Parenteral | 1 | 1984 | 397 | 0.010 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2004 | 105 | 0.010 |
Why?
|
| Factor Xa | 1 | 1985 | 166 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 14599 | 0.010 |
Why?
|
| Pluripotent Stem Cells | 1 | 2011 | 796 | 0.010 |
Why?
|
| Plasma Volume | 1 | 2003 | 31 | 0.010 |
Why?
|
| Triazenes | 1 | 2003 | 8 | 0.010 |
Why?
|
| Infant | 3 | 2016 | 36157 | 0.010 |
Why?
|
| Metalloporphyrins | 1 | 2004 | 41 | 0.010 |
Why?
|
| Ribose | 1 | 2004 | 63 | 0.010 |
Why?
|
| WT1 Proteins | 1 | 2004 | 184 | 0.010 |
Why?
|
| Multicenter Studies as Topic | 1 | 1989 | 1700 | 0.010 |
Why?
|
| Blood Urea Nitrogen | 1 | 2003 | 185 | 0.010 |
Why?
|
| Thermodynamics | 1 | 1985 | 593 | 0.010 |
Why?
|
| Injections, Intra-Arterial | 1 | 2003 | 181 | 0.010 |
Why?
|
| Streptococcal Infections | 1 | 1988 | 617 | 0.010 |
Why?
|
| Amphotericin B | 1 | 1984 | 142 | 0.010 |
Why?
|
| Hindlimb | 1 | 2005 | 513 | 0.010 |
Why?
|
| Lipid Bilayers | 1 | 2005 | 383 | 0.010 |
Why?
|
| Embryo Implantation | 1 | 2005 | 270 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 3419 | 0.010 |
Why?
|
| Alcoholic Intoxication | 1 | 1984 | 174 | 0.010 |
Why?
|
| Plethysmography | 1 | 2003 | 175 | 0.010 |
Why?
|
| Thiamine | 1 | 1984 | 160 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2023 | 26183 | 0.010 |
Why?
|
| Hypertrophy | 1 | 2005 | 560 | 0.010 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2015 | 1851 | 0.010 |
Why?
|
| Dextrans | 1 | 1985 | 573 | 0.010 |
Why?
|
| Blood Coagulation Tests | 2 | 1995 | 271 | 0.010 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 1986 | 451 | 0.010 |
Why?
|
| Regression Analysis | 1 | 1992 | 6339 | 0.010 |
Why?
|
| Arteriovenous Fistula | 1 | 1986 | 319 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1985 | 1433 | 0.010 |
Why?
|
| Heart Septum | 1 | 2004 | 299 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2020 | 12942 | 0.010 |
Why?
|
| Tissue Donors | 1 | 2012 | 2329 | 0.010 |
Why?
|
| Proteoglycans | 1 | 2006 | 803 | 0.010 |
Why?
|
| Genes | 1 | 1986 | 1823 | 0.010 |
Why?
|
| Bronchoconstrictor Agents | 1 | 2002 | 77 | 0.010 |
Why?
|
| Dinoprostone | 1 | 2005 | 597 | 0.010 |
Why?
|
| Pericardium | 1 | 1987 | 664 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2014 | 3820 | 0.010 |
Why?
|
| Protein Precursors | 1 | 1986 | 1131 | 0.010 |
Why?
|
| Disclosure | 1 | 2008 | 747 | 0.010 |
Why?
|
| Comet Assay | 1 | 2002 | 75 | 0.010 |
Why?
|
| Reference Standards | 1 | 2005 | 1003 | 0.010 |
Why?
|
| Immediate-Early Proteins | 1 | 2004 | 444 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2004 | 546 | 0.010 |
Why?
|
| Hypertrophy, Right Ventricular | 1 | 2002 | 109 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 1995 | 4408 | 0.010 |
Why?
|
| Thymidine | 1 | 2002 | 297 | 0.010 |
Why?
|
| Lipoxygenase Inhibitors | 1 | 2002 | 93 | 0.010 |
Why?
|
| Dietary Fats | 1 | 1989 | 1995 | 0.010 |
Why?
|
| Tritium | 1 | 2002 | 706 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 1993 | 8516 | 0.010 |
Why?
|
| Renin | 1 | 2003 | 640 | 0.010 |
Why?
|
| Benzoquinones | 1 | 2002 | 198 | 0.010 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2004 | 488 | 0.010 |
Why?
|
| Anticholesteremic Agents | 1 | 2008 | 967 | 0.010 |
Why?
|
| Ventricular Function | 2 | 1996 | 406 | 0.010 |
Why?
|
| Patient-Centered Care | 1 | 2011 | 1419 | 0.010 |
Why?
|
| Prejudice | 1 | 2005 | 571 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 2003 | 1089 | 0.010 |
Why?
|
| Age Factors | 1 | 1997 | 18381 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8652 | 0.010 |
Why?
|
| Protons | 1 | 2005 | 1112 | 0.010 |
Why?
|
| Vasculitis | 1 | 2004 | 522 | 0.010 |
Why?
|
| Blood Physiological Phenomena | 1 | 1999 | 53 | 0.010 |
Why?
|
| Growth Substances | 1 | 2002 | 768 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2012 | 42193 | 0.010 |
Why?
|
| Intestinal Mucosa | 2 | 1993 | 3031 | 0.010 |
Why?
|
| Glycosylation | 1 | 2002 | 1098 | 0.010 |
Why?
|
| Tomography, Emission-Computed | 1 | 2002 | 1122 | 0.010 |
Why?
|
| Exchange Transfusion, Whole Blood | 1 | 1999 | 59 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2009 | 2977 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 2002 | 1369 | 0.010 |
Why?
|
| Endothelins | 1 | 1998 | 127 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 1990 | 3607 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2006 | 6188 | 0.010 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 1976 | 162 | 0.010 |
Why?
|
| Trachea | 2 | 1993 | 1089 | 0.010 |
Why?
|
| Isoproterenol | 1 | 1996 | 397 | 0.010 |
Why?
|
| Genes, myc | 1 | 1997 | 390 | 0.010 |
Why?
|
| Biotin | 1 | 1997 | 252 | 0.010 |
Why?
|
| Blood Cells | 1 | 1998 | 305 | 0.010 |
Why?
|
| Blood Transfusion, Autologous | 1 | 1996 | 130 | 0.010 |
Why?
|
| Microelectrodes | 1 | 1997 | 306 | 0.010 |
Why?
|
| Heart Valve Diseases | 1 | 1984 | 1028 | 0.010 |
Why?
|
| Myosin Subfragments | 1 | 1975 | 20 | 0.010 |
Why?
|
| Organic Chemicals | 1 | 1996 | 210 | 0.010 |
Why?
|
| Informed Consent | 1 | 2002 | 1007 | 0.010 |
Why?
|
| Cornea | 1 | 2003 | 1332 | 0.010 |
Why?
|
| Genes, p53 | 1 | 1997 | 712 | 0.010 |
Why?
|
| Graft Survival | 1 | 2006 | 3814 | 0.010 |
Why?
|
| Cobalt | 1 | 1995 | 154 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2008 | 4745 | 0.010 |
Why?
|
| Viscosity | 1 | 1975 | 336 | 0.010 |
Why?
|
| Cytoplasmic Granules | 1 | 1997 | 573 | 0.010 |
Why?
|
| Family Health | 1 | 1999 | 1253 | 0.010 |
Why?
|
| Nicorandil | 1 | 1994 | 2 | 0.010 |
Why?
|
| Muscarinic Antagonists | 1 | 1995 | 135 | 0.010 |
Why?
|
| Molsidomine | 1 | 1993 | 22 | 0.010 |
Why?
|
| Manganese | 1 | 1976 | 393 | 0.010 |
Why?
|
| Video Recording | 1 | 1999 | 965 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 1995 | 522 | 0.010 |
Why?
|
| Injections | 1 | 1996 | 832 | 0.010 |
Why?
|
| Platelet Transfusion | 1 | 1996 | 298 | 0.010 |
Why?
|
| Diptera | 1 | 1993 | 50 | 0.010 |
Why?
|
| Indoles | 1 | 2002 | 1830 | 0.010 |
Why?
|
| Cerebrovascular Circulation | 1 | 2003 | 2726 | 0.010 |
Why?
|
| Models, Structural | 1 | 1973 | 340 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1994 | 861 | 0.010 |
Why?
|
| Nitrous Oxide | 1 | 1994 | 166 | 0.010 |
Why?
|
| Magnesium | 1 | 1976 | 804 | 0.010 |
Why?
|
| X-Ray Diffraction | 1 | 1973 | 421 | 0.010 |
Why?
|
| Crystallization | 1 | 1973 | 533 | 0.010 |
Why?
|
| beta Carotene | 1 | 1993 | 523 | 0.010 |
Why?
|
| Charybdotoxin | 1 | 1991 | 23 | 0.010 |
Why?
|
| Molecular Conformation | 1 | 1973 | 544 | 0.010 |
Why?
|
| Scorpion Venoms | 1 | 1991 | 29 | 0.010 |
Why?
|
| Swine, Miniature | 1 | 1994 | 961 | 0.010 |
Why?
|
| Body Fluids | 1 | 1993 | 320 | 0.010 |
Why?
|
| Ovariectomy | 1 | 1994 | 613 | 0.010 |
Why?
|
| Pedigree | 1 | 1999 | 4539 | 0.010 |
Why?
|
| Patient Compliance | 1 | 1991 | 2688 | 0.010 |
Why?
|
| Methacholine Compounds | 1 | 1990 | 35 | 0.010 |
Why?
|
| Cause of Death | 1 | 1991 | 3683 | 0.010 |
Why?
|
| Vitamin A | 1 | 1993 | 612 | 0.010 |
Why?
|
| Immunohistochemistry | 2 | 1994 | 11069 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2004 | 5789 | 0.010 |
Why?
|
| Muscle Contraction | 1 | 1994 | 1200 | 0.010 |
Why?
|
| Phenylephrine | 1 | 1990 | 293 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 1995 | 1734 | 0.010 |
Why?
|
| Veins | 1 | 1994 | 767 | 0.010 |
Why?
|
| Hydroxymethylglutaryl-CoA Synthase | 1 | 1989 | 15 | 0.010 |
Why?
|
| Perfusion | 1 | 1993 | 1373 | 0.000 |
Why?
|
| Multivariate Analysis | 1 | 2001 | 12043 | 0.000 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 1993 | 894 | 0.000 |
Why?
|
| Arm | 1 | 1990 | 588 | 0.000 |
Why?
|
| Stents | 1 | 1999 | 3177 | 0.000 |
Why?
|
| Lipase | 1 | 1989 | 324 | 0.000 |
Why?
|
| Preoperative Care | 1 | 1995 | 2242 | 0.000 |
Why?
|
| Monosaccharides | 1 | 1986 | 66 | 0.000 |
Why?
|
| Antibodies | 1 | 1994 | 2413 | 0.000 |
Why?
|
| Glycoside Hydrolases | 1 | 1986 | 135 | 0.000 |
Why?
|
| Pleura | 1 | 1987 | 244 | 0.000 |
Why?
|
| Ristocetin | 1 | 1985 | 26 | 0.000 |
Why?
|
| Linear Models | 1 | 1994 | 5866 | 0.000 |
Why?
|
| Scattering, Radiation | 1 | 1985 | 490 | 0.000 |
Why?
|
| Isoantigens | 1 | 1985 | 551 | 0.000 |
Why?
|
| Microscopy, Electron | 1 | 1985 | 2561 | 0.000 |
Why?
|
| Angiography | 1 | 1987 | 1595 | 0.000 |
Why?
|
| Plasmids | 1 | 1986 | 2265 | 0.000 |
Why?
|
| Light | 1 | 1985 | 1352 | 0.000 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 1993 | 2423 | 0.000 |
Why?
|